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ABSTRACT 
 Due to their unique electronic, optical, catalytic and mechanical properties, 
nanomaterials (nanoparticles and nanotubes) have been attracting much attention 
over the past decades. In this dissertation, polymeric nanoparticles bearing 
derivatized D-mannose and galactose molecules were prepared via dispersion 
polymerization and their interactions with various bacterial cells were studied. 
The results show that there are strong adhesin-specific interactions of the 
nanoparticles with E. coli cells, resulting in significant nanoparticles-madiated 
cell agglutination. 
  Poly(ethylene glycol)-coated magnetic polymer nanoparticles were 
synthesized through miniemulsion polymerization by using macromonomer as 
both a comonomer and a surfactant. The resulting magnetic polymer nanoparticles 
were successfully used for bio-detection and as magnetic resonance imaging 
(MRI) contrast agents. 
  The functionalization of carbon nanomaterials was also studied. Carbon 
nanotubes and vapor grown carbon nanofibers (VGCFs) were functionalized and 
solubilized with nylon 6 by using the grafting-from strategy in a two-step process. 
These nylon-functionalized carbon nanomaterials were systematically 
characterized and used for the fabrication of polymer/carbon composite fibers by 
electrospinning method. 
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OUTLINE OF DISSERTATION 
 
 My graduate research concerns the synthesis, characterization and 
applications of functionalized nanomaterials, including polymeric nanoparticles 
and carbon nanotubes. Among the various biological processes in which 
carbohydrate-protein interactions are involved, the attachment of pathogens such 
as Escherichia coli to host cells is of particular therapeutic interest. It is 
reasonable to use carbohydrates to block their counterpart proteins to prevent the 
adhesion process, and the literature reports that various substrates bearing 
multiple carbohydrates have been used for this very purpose. We synthetically 
prepared polymeric nanoparticles that are covalently functionalized with 
derivatized D-mannose and galactose molecules. Their interactions with bacterial 
cells were tested by our collaborator Dr. Tzuen-Rong Tzeng in the Department of 
Biological Sciences at Clemson University. The results show that there are strong 
adhesin-specific interactions of the nanoparticles with E. coli cells, resulting in 
significant nanoparticles-mediated cell agglutinations, which can easily be 
visualized in terms of electron microscopy imaging. Therefore, these 
carbohydrate-conjugated polymeric nanoparticles may not only provide a unique 
platform for the visualization of the cell agglutination, but also potentially serve 
as therapeutic agents for the inhibition of pathogenic infections (Chapter 1 and 2).   
 The synthesis, characterization, and application of poly(ethylene glycol)-
coated magnetic polymer nanoparticles is the second focus of my graduate 
  
 
xxvi
research. There has been strong interest in the preparation of magnetic polymer 
nanoparticles for use in such biomedical applications as drug delivery, magnetic 
resonance imaging, and cell separation. We prepared poly(ethylene glycol)-coated 
magnetic polymer nanoparticles through miniemulsion polymerization by using 
macromonomer as both a comonomer and a surfactant. Compared with those 
previously reported in the literature, our magnetic polymer nanoparticles have the 
following advantages: (1) poly(ethylene glycol) are covalently attached to the 
polystyrene core, providing much better stability in various environments; (2) 
surfaces covered with PEG have proven to be nonimmunogenic, nonantigenic, 
and protein resistants and (3) more functional groups will be available for the bio-
functionalization of those nanoparticles. These nanoparticles were also used for 
the detection of L. monocytogenes in artificially contaminated milk in Dr. Xiuping 
Jiang’s group in the Department of Food Science & Human Nutrition at Clemson 
University, showing great advantages over the commercially available 
Dynabeads. These magnetic polymer nanoparticles were also used as contrast 
agents for magnetic resonance imaging (Chapter 3). 
 Functionalization of carbon nanomaterials such as carbon nanotubes and 
carbon nanofibers and their composites is the third focus of my graduate research. 
The carbon nanomaterials especially carbon nanotubes (both single wall SWNTs 
and multiwall MWNTs) and vapor grown carbon nanofibers (VGCNFs) have 
shown exceptional physical, mechanical, electrical, thermal, and optical 
properties. The dispersion of carbon nanotubes and carbon nanofibers into 
polymeric materials has received much attention for both fundamental and 
  
 
xxvii
practical interests in polymeric/carbon nanocomposites. The solubilization of 
carbon nanotubes has been identified as an effective means of dispersing the 
nanotubes homogeneously in wet processing. We functionalized carbon 
nanotubes and VGCNFs with nylon 6 by using the grafting-from strategy in a 
two-step process, where the covalent attachment of ε-caprolactam molecules to 
nanotubes/nanofibers was followed by the anionic ring-opening polymerization of 
these bound ε-caprolactam species with the same monomers in bulk. The nylon-
functionalized carbon nanomaterials were systematically characterized and used 
for the fabrication of polymer/carbon composite fibers by electrospinning method 
(Chapter 4 and 5). 
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CHAPTER 1 
CARBOHYDRATE-CONJUGATED NANOPARTICLES 
 
1.1 Introduction 
 Over the last two decades, there has been strong interest in research aimed at 
fabricating hybrid nanomaterials from nanoparticles (exhibiting unique electronic, 
photonic, and catalytic properties) and biomolecules (displaying unique 
recognition, catalytic and inhibition properties).1,2 Nanoparticles including metal, 
semiconductor, and polymeric ones, have similar dimensions to those of 
biomolecules, such as proteins (enzyme, antigens, antibodies) and DNAs (Figure 
1.1).1 The conjugation of nanoparticles with biomolecules yields novel hybrid 
biomaterials that can be used as interesting tools for mimicking biofunctional 
systems, studying the mechanism of biological processes, as well as developing 
chemical means to handle and manipulate biological components.2 
 Recently, proteins and DNAs have been widely studied in the conjugation 
with nanoparticles. These resulting nanomaterials have been used for the 
engineering of advanced technical devices and in the industrial production of 
active substances for pharmaceutical and biomedical applications.1 The literature 
cites many such examples; Nie et al. reported mercaptoacetic acid-stabilized ZnS-
protected CdSe QDs, which were coupled with transferrin, a protein that induces 
receptor-mediated endocytosis.3 Confocal microscopy revealed that the 
  2
 
Figure 1.1 A gap currently exists in the engineering of small-scale 
devices. As a result of their own dimensions, two different types of 
compounds appear to be suited for addressing that gap: 1) 
biomolecular components, such as proteins, and nucleic acids, and 2) 
colloidal nanoparticles. (From Ref. [1].) 
  3
nanoparticle-protein conjugates were transported into the Hela cells upon 
incubations. In another example, Mirkin and co-workers4 as well as other groups5-
9 reported the DNA-directed immobilization of gold nanoparticles that 
subsequently formed supramolecular architecture on surfaces. The specific 
nucleic acid mediated immobilization of gold nanoparticles were utilized for the 
topographic labeling of surface-bound DNA targets, which allowed the highly 
sensitive scanometric detection of nucleic acids in DNA chip analyses.10 Several 
reviews on nanomaterials conjugated with proteins and DNA have also been 
published in the literature.1,2,11,12,13  
 Carbohydrates are one of four major classes of macromolecules in biology 
(together with DNAs, proteins, and lipids) that play important roles in biological 
processes. For example, it is known that carbohydrate conjugates on the cell 
surfaces are involved in the control of many normal and pathological processes.14-
19 In order to achieve these relevant biofunctions, carbohydrates usually appear in 
the form of clusters or in a multivalent fashion on either cell or tissue surfaces.21 
However, reports on carbohydrate-conjugated nanoparticles in the literature are 
rather scarce when compared to those on DNA- and protein-based conjugates,20 
probably due to the weak interactions between carbohydrates and the 
complementary biomolecules (Kd on the order of 10-3 M for 1:1 complexes). 
Nevertheless, the synthesis of carbohydrate-conjugated nanoparticles and their 
applications in glycoscience, biomedicine and material science will be briefly 
discussed in this chapter. 
 
  4
1.2 Synthesis of carbohydrate-conjugated nanoparticles 
 Many kinds of nanoparticles that exhibit carbohydrate conjugation have been 
reported in the literature. The core material of the nanoparticles can be gold, 
silver, cadmium sulfide, zinc sulfide, iron oxide, and organic polymers, and the 
synthesis of each type of carbohydrate-conjugated nanoparticles is discussed in 
detail below.  
 
 Carbohydrate-conjugated gold nanoparticles. Gold nanoparticles have 
unique optical and chemical properties that make them suitable for a number of 
applications in bionanotechnology, including optical probes, targeted drug 
delivery, and programmed material synthesis.22 Brust and Schiffrin reported an 
easy and reproducible synthesis of gold nanoparticles for the first time in 1994.23 
The synthesis involved the phase transfer of an anionic AuIII complex from 
aqueous to organic solution in a two-phase liquid/liquid system, followed by the 
reduction with NaBH4 in the presence of thiol stabilizing ligands. This synthesis 
route has been extensively studied and widely used in the preparation of gold 
nanoparticles functionalized with proteins and DNA.1 Also based on this method, 
Penades et al.24 reported the first synthesis of carbohydrate-conjugated gold 
nanoparticles, which was accomplished by adding thiol-derivalized 
neoglyconjugate to an aqueous solution of tetrachloroauric acid (HAuCl4) and a 
subsequent reduction with NaBH4 (Figure 1.2). Similarly, a series of 
carbohydrate-conjugated gold nanoparticles were prepared with the trisaccharide 
Lex (Galβ1-4[Fucα1-2]GlcNAcβ1),24 monosaccharide glucose, the disaccharides 
  5
lactose (Galβ1-4Glcβ1) and maltose (Glcα1-4Glcβ1),25 and the tetrasaccharide 
Ley ([Fucα1-2]Galβ1-4[fucα1-2]GlcNAcβ1).26 These nanoparticles are stable and 
soluble in water, allowing their convenient manipulation as biocompatible 
macromolecules. 
 Several other groups also used the Brust’s method to prepare various 
carbohydrate-conjugated gold nanoparticles. For example, Kataoka et al.27 
obtained lactose-conjugated gold nanoparticles with an average core diameter of 
8.9 nm by reduction of the metal salt with NaBH4 in the presence of acetal-PEG-
SH. The PEG acetal terminal groups were converted to aldehydes via gentle acid 
treatment, followed by the reaction with p-aminophenyl-b-D-lactopyranoside in 
the presence of (CH3)2NHBH3. Terminal lactose content can be regulated by 
varying the molar ratio of p-aminophenyl-lactose with p-aminophenyl-mannose in 
reaction mixtures, respectively (Figure 1.3). Gervay-Hague et al.28 prepared 
glucose- and galactose-conjugated gold nanoparticles and Lin et al.29 synthesized 
gold nanoparticles conjugated with mannose, glucose and galactose. Kamerling et 
al.30 reported a series of water-soluble gold nanoparticles conjugated with 
glycosides β-D-GlcpNAc3S-(1-3)-α-L-Fucp-(1-O)(CH2)3S(CH2)6SH, β-D-
GlcpNAc3S-(1-3)-β-L-Fucp-(1-O)(CH2)3S(CH2)6SH, β-D-GlcpNAc3S-(1-
O)(CH2)3S-(CH2)6SH, α-L-Fucp-(1-O)(CH2)3S(CH2)6SH, β-D-Glcp-NAc3S-(1-3)-
α-L-Galp-(1-O)(CH2)3S(CH2)6SH, β-D-Glcp-NAc-(1-3)-α-L-Fucp-(1-
O)(CH2)3S(CH2)6SH, and β-D-Glcp3S-(1-3)-α-L-Fucp-(1-O)(CH2)3S(CH2)6SH. 
Barchi et al.31 described the synthesis of gold nanoshells encapsulated with up to 
90 units of the Thomsen-Friedenreich (TF) tumor-associated carbohydrate antigen 
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disaccharide (Galβ1-3GalNAc-α-O-Ser/Thr). The assembly of a suitably linked 
designer glycopeptides as a precursor to similar multivalent presentations on gold 
was also reported. 
 
 Carbohydrate-conjugated silver nanoparticles. Silver nanoparticles have 
been shown to cause surface-enhanced fluorescence, which was attributed to an 
enhanced field near the silver surface. Russell et al.32 prepared the mannose-
conjugated silver nanoparticles, first through the reduction of a silver salt with 
NaBH4, next followed by the addition of 2-mercaptoethyl α-D-mannopyranoside. 
Lakowicz et al.33 synthesized dextran- and glucose-conjugated silver 
nanoparticles in a modified Brust reaction with a 1:1 molar ratio of tiopronin and 
silver nitrate in methanol. Tiopronin ligands coated on silver nanoparticles were 
displaced by thiolate boronic acid through ligand exchange, which were then 
coupled with dextran and glucose (Figure 1.4) 
 
 Carbohydrate-conjugated quantum dots. One of the fastest moving and 
most exciting endeavors in current nanotechnology research is the use of highly 
luminescent inorganic nanoparticles, or quantum dots (QDs), as fluorescence 
probes in biology.3,34,35,36 Popular core materials for QDs include CdS, CdSe, etc. 
Compared to conventional fluorescent dyes, QDs have four distinct advantages: 
(1) QDs fluorescence absorption and emission are conveniently tunable by their 
sizes and material compositions, and the emission peaks are of narrow spectral 
linewidths; (2) QDs have high quantum yields that often range from 35-50% for
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Figure 1.2 Preparation of the disaccharide lactose- and the 
trisaccharide Lewisx-conjugated gold nanoparticles. (From Ref. 
[24].) 
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Figure 1.3 Preparation of functionalized gold nanoparticles covered with 
heterobifunctional PEG. (From Ref. [27].) 
  9
 
Figure 1.4 Preparation of tiopronin-monolayer-protected silver 
nanoparticle, ligand exchange, and coupling with saccharide. (From Ref. 
[33].) 
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core (CdSe)-shell (ZnS) nanoparticles; (3) QDs are approximately 100 times as 
stable against photobleaching as organic dyes; and (4) QDs often have a long 
fluorescence lifetimes of several hundred nanoseconds. There are two synthetic 
procedures that are used to produce QDs with the desired optical properties for 
biomedical research and applications. The first is an organometallic synthetic 
procedure developed by Murray et al.37 The second is known as the “Greener” 
method, which uses environmentally more benign metallic salts and organic 
stabilizing agents.38,39,40 Recently, peptides and proteins, antibodies, DNAs and 
other small ligands were successfully conjugated to the surface of QDs through 
the “Greener” method. QD–streptavidin conjugates, for example, have been used 
to stain tissues, cells, and intracellular organelles.34 Likewise, QD–avidin–
antibody conjugates improved the sensitivity of conventional 
fluoroimmunoassays.3 However, there are few reported examples on the synthesis 
of carbohydrate-conjugated QDs. The first carbohydrate-conjugated QDs was 
reported by Rosenzweig et al,41 who successfully incorporated negatively charged 
luminescent CdSe-ZnS QDs into novel luminescent glyconanospheres averaging 
190 nm in diameter through electrostatic interactions with carboxymethyldextran 
and polylysine. The resulting dextran-conjugated QDs showed high affinity 
toward the glucose binding protein-Concanavalin A (Con A). Sun et al.42 reported 
the site-specific multivalent carbohydrate labeling of QD surface using a biotin 
chain-end-functionalized glycopolymer, thusly demonstrating the potential value 
of these multivalent carbohydrate polymers in both imaging and biocapture 
applications. Penades et al.43 prepared, for the first time, water soluble CdS 
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nanoclusters functionalized with biologically significant oligosaccharides by 
means of a straightforward one-step procedure (Figure 1.5). These 
oligosaccharides-conjugated QDs displayed the carbohydrate antigens in a three-
dimensional and polyvalent array, mimicking glycosphingolipid presentation on 
the cell surface and providing a convenient tool for studying and interfering 
carbohydrate-mediated cell-cell adhesion process. Fang et al.44 reported the 
encapsulation of QDs with biologically important β-N-acetylglucosamine, which 
specifically bound to wheat germ agglutinin, caused subsequent fluorescence 
quenching and aggregation. Liu et al.45 synthesized β-cyclodextrin (β-CD)-
modified CdSe (β-CD/CdSe) and CdSe-CdS core-shell structured (β-CD/CdSe-
CdS) QDs by a single-phase approach in aqueous solutions. These highly 
quantum efficient, water soluble receptor-modified QDs may serve as active 
component in the construction of QD-based hybrid nanomaterials for practical 
applications, such as in clinical diagnosis and solar energy conversion. 
 
 Carbohydrate-conjugated polymeric nanoparticles. Many researchers have 
conjugated carbohydrates onto water-soluble synthetic linear polymers.46,47 
However, research on the conjugation of sugars onto polymeric nanoparticles is 
much less common.  
 Maruyama et al.48 described a novel method of preparing polymeric 
nanoparticles bearing high density carbohydrate chains on their surfaces. 
Carbohydrate-bearing nanoparticles of poly(lactic acid) or polystyrene were 
prepared by the solvent evaporation method using a carbohydrate-carrying
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Figure 1.5 Preparation of glyco-QDs. Reagents and conditions: (a) Cd(NO3)2·4H2O, 
Na2S, pH 10, H2O. (From Ref. [43].) 
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 polystyrene derivative which served as both an emulsifier and the surface 
coating. The obtained particles were specifically aggregated by a carbohydrate-
specific lectin, showing that the polystyrene derivative was retained on the 
particle surfaces with expressed carbohydrate residues. 
 Cho et al.49 reported the preparation of nanoparticles bearing carbohydrate 
chains on the surface by the simple one-step diafiltration method. The resulting 
nanoparticles, which did not aggregate, were of high yield, small size, and narrow 
size distribution. The high-density carbohydrate chains on the particles could also 
be readily recognized by cells. 
 Akashi et al. developed a method for the preparation of “core-corona 
nanospheres”, namely nanoparticles with a hydrophobic polymer core and 
hydrophilic polymer corona containing functional groups.50,51 Through an amide 
linkage between a lactose-lactose and the primary amine group, they successfully 
conjugated lactose onto nanoparticles with a polystyrene core and a 
poly(vinylamine) corona, and analyzed the binding of the resultant carbohydrate-
conjugated nanoparticles with lactose-specific Ricinus communis agglutinin 
(RCA120) (Figure 1.6).52,53 they also synthesized a glucose-containing 
macromonomer, and copolymerized it with a styrene in order to prepare 
polystyrene core-glucose corona nanoparticles.54  
 Similarly, Sun et al.55 synthesized mannosylated polystyrene nanoparticles via 
dispersion polymerization. The mannosylated polymeric nanoparticles were 
effective in the agglutination of E. coli ORN178 via adhesion-specific 
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interactions, and the nanoparticles-mediated bacteria cell agglutination was 
conveniently visualized by using typical electron microscopy methods. 
 Recently, mixed micelle methodologies were employed to construct 
nanoparticle scaffolds with a hydrophobic core, a hydrophilic cross-linked shell, 
and several different stoichiometries of surface-displayed mannoside groups.56 
Specifically, the conjugation of mannose onto the hydrophilic chain terminus of 
the amphiphilic diblock copolymer precursor was achieved by the growth of the 
diblock copolymer from a mannoside-functionalized initiator under typical Atom 
Transfer Radical Polymerization (ATRP). Mixed micelle formation between the 
amphiphilic diblock copolymer and mannosylated amphiphilic diblock copolymer 
was then undertaken, followed by condensation-based cross-linking between the 
acrylic acid residues present in the periphery of the polymer micelles to afford 
SCK nanoparticles (Figure 1.7). The content of the mannose functionalities was 
able to be adjusted by controlling the stoichiometric ratios of mannosylated and 
nonmannosylated diblock polymers. 
 
1.3 Applications of Carbohydrate-Conjugated Nanoparticles 
 Due to their size range, surface properties, and other physical properties, 
carbohydate-conjugated nanopaticles are ideal bio-mimetic model systems for use 
on cell surfaces with displayed sugars, and are thus widely used in the studies of 
carbohydrate-protein interactions and carbohydrate-carbonhydrate interactions. 
Other applications of these nanoparticles include biolabels and biosensors.
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Figure 1.6 Schematic representation of a lactose-immobilized 
nanosphere and subsequent hepatocyte binding. (From Ref. [53].) 
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Figure 1.7 Construction of mannosylated SCK nanoparticles, with 
control over the number of mannose residues being provided by the 
formation of mixed micelles. (From Ref. [56].) 
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 Carbohydrate-conjugated nanoparticles in carbohydrate-protein 
interactions. While carbohydrate-protein interactions are of fundamental 
importance for a large number of physiological events, monovalent carbohydrate-
protein interactions are typically associated with weak binding constants, which, 
by nature, can be compensated by the presentation of multiple ligands to 
individual receptors. The polyvalent interactions between multiple ligands and 
their receptors can, collectively, be much stronger than corresponding monovalent 
interactions. In order to better understand these interactions, linear polymers, and 
other two- and three-dimensional species bearing multiple mannose molecules 
have been developed and used to facilitate the required multivalent binding.56-62 
 Several groups have used carbohydrate-conjugated nanoparticles to study the 
carbohydrate-protein interactions. Among the earliest reports, Kataoka et al. 
observed that lactose-conjugated gold nanoparticles exhibited selective 
aggregation when exposed to Recinus communis agglutinin (RCA120), a bivalent 
lectin. RCA120 specifically recognizes the β-D-galactose residue, causing 
significant changes in the absorption spectrum with a concomitant visible color 
change from pinkish-red to purple (Figure 1.8).27 Furthermore, the degree of 
aggregation was proportional to lectin concentration and lactose density on the 
surface of the particles, permitting the system to be utilized for quantitative 
assay.27 
 The surface plasma resonance (SPR) technique can be applied to 
quantitatively analyze the carbohydrate-protein interactions together with 
carbohydrate-conjugated nanoparticles. Lin et al.29 determined that the binding
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Figure1.8 Schematic representation of the reversible aggregation 
dispersion behavior of Lactose-PEGylated gold nanoparticles by 
sequential addition of RCA120 lectin and galactose with actual 
concommitant change in color from pinkish-red to purple to pinkish-
red. (From Ref. [27].) 
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between mannose-conjugated nanoparticles and Con A exhibited a strong 
multivalent effect, while also determining that the affinity could be adjusted by 
altering the nanoparticles size or sugar moiety.  
 Russell et al.63 reported a rapid, quantitative colorimetric detection of 
carbohydrate binding proteins using mannose-stabilized gold nanoparticles. The 
sizes of the mannose-stabilized gold nanoparticles provide specific optical 
properties for the colorimetric determination of sub-µM concentrations of the 
lectin Con A. By measuring the intensity change of the surface plasmon 
absorption band at 620 nm, the selective aggregation process can be used to 
provide quantitative and rapid data acquisition. 
 
 Carbohydrate-conjugated nanoparticles in carbohydrate-carbohydrate 
interactions. Carbohydrates, the most prominently exposed structures on the 
surface of living cells, are integral components in cell-cell adhesion and 
communication. Since Hakomori’s initial report in 1989, detailing how 
glycosphingolipid self-interactions occur by way of the Lewisx determinant 
(Galβ1-4[Fucα1-3] GlcNAcβ1-3Galβ1-4Glcβ) (Lex), resulting in Lex 
carbohydrate-dependent cell adhesion in the compaction of mouse embryos,64 
several other glycosphingolipids involved in carbohydrate-carbohydrate 
interactions have already been identified. These carbohydrate-carbohydrate 
interactions include KDNGM3-Gg3 interaction in the binding of sperm to egg 
membranes in rainbow trout fertilization65 and the GM3-Gg3 interaction between 
lymphoma and melanoma cells. 66 
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 Various model systems have been proposed to investigate these carbohydrate-
carbohydrate interactions. Because such interactions are weak by nature, several 
groups used clustered oligosaccharides as model systems for these investigations. 
Penades et al.24 devised Lex-coated gold nanoparticles to investigate the selective 
self-recognition of the Lex antigen through carbohydrate-carbohydrate 
interactions. The aggregation of the Lex-coated nanoparticles in the presence of 
Ca2+ via the homotropic Lex-Lex interactions were verified by transmission 
electron microscopy (TEM) (Figure 1.9). In the same report, the first quantitative 
kinetic data for Lex self-recognition and direct evidence of its Ca2+ dependency 
were also provided. Furthermore, isothermal titration calorimetry was used to 
show that the Ca2+-mediated aggregation is a slow process that occurs with a 
decrease in enthalpy of 160 ± 30 kcal/mol, while the heat evolved in the case of 
lactose and maltose glyconanoparticles is very low and thermal equilibrium was 
quickly achieved in the experiment.67,68 
 Similarly, water-soluble gold glyconanoparticles coated with synthetic 
carbohydrates related to the sulfated disaccharide fragment were used as 
multivalent systems to investigate the g-200 glycan-glycan interactions by TEM.69 
 Very recently, Russell et al.70 reported that the self-assembled deposition of 
lactose derivatives on gold nanoparticles provides multivalent carbohydrate 
surfaces that can be used to mimic the measurement of biologically relevant 
carbohydrate-carbohydrate interactions. They determined that the aggregation of 
lactose nanoparticles were quantitatively dependent on calcium ion concentration, 
while the analytical sensitivity and working dynamic range of the calcium-
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induced aggregation were dependent upon the length of the ethylene glycol chain 
(Figure 1.10). 
 
 Carbohydrate-conjugated nanoparticles as biolabels. Although 
nanoparticles functionalized with proteins, peptides, and nucleic acids have been 
extensively used as biolabels in biology,1 only a handful of reports in the literature 
have reported the use of carbohydrate-conjugated nanoparticles to explore the 
analogous applications of biolabels. 
 Lin et al.61 first reported a method of labeling specific proteins on the cell 
surfaces using mannose-conjugated gold nanoparticles. These nanoparticles were 
tested for their ability to bind to mannose-specific adhesin FimH of type 1 pili in 
Escherichia coli. Two E. coli strains - ORN178 (expressing wild-type type 1 pili) 
and ORN208 (deficient of the FimH gene and expressing abnormal type 1 pili that 
failed to mediate D-mannose-specific binding) - were used in experiments to 
confirm the specific binding of the mannose-conjugated nanoparticles to FimH. It 
was also determined, through TEM, that the particles bound specifically to FimH 
adhesion of bacteria type 1 pili; the interactions were stronger than with free 
mannose only, as revealed in the competition assay (Figure 1.11). This discovery 
suggested that the strong and selective nanoparticle-adhesin binding might be 
used as a novel route for the labeling of specific proteins on the cell surface. A 
significant advantage for the use of these carbohydrate-conjugated nanoparticles 
is that the target receptors on the cell surface could be detected easily under an 
electron microscope. 
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Figure 1.9 Transmission electron micrographs and core size-distribution 
histograms (insets in a, b) of: a) 3-Au (0.1 mgmL-1 in water); b) 2-Au (0.1 
mgmL-1 in water); c) 3-Au (0.1 mgmL-1 in 10 mm CaCl2 solution); d) 3-Au 
(0.9 mgmL-1 in 10 mm CaCl2 solution); e) the same as (c). EDTA; f) the 
same as (d).EDTA; g) 2-Au (0.1 mgmL-1 in 10 mm CaCl2 solution); h) 2-Au 
(0.9 mgmL-1 in 10 mm CaCl2 solution); EDTA = ethylendiaminetetraacetate. 
(From Ref. [24].) 
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Figure 1.10 Schematic representation of the formation of large 
aggregates following calcium-mediated carbohydrate-carbohydrate 
interaction of the lactose nanoparticles. (From Ref. [70].) 
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Figure 1.11 Typical TEM images of sectioned areas of (A) pili of the 
E. coli ORN178 strain bound with m-AuNP, (B) the E. coli ORN208 
strain deficient of the fimH gene without m-AuNP binding. The 
experiments were performed in LB at room temperature. Scale bar = 
100 nm. (From Ref. [61].) 
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 Sun et al.54 employed a similar approach. In their experiments they used 
mannosylated polymeric nanoparticles as biolabels, and synthesized 
mannosylated polymeric nanoparticles in the dispersion polymerization of 
mannosylated macromonomer with styrene in ethanol-water (4/1, v/v) mixture. 
The resulting nanoparticles were quite effective in the agglutination of E. coli 
ORN178 via adhesion-specific interactions, with such significant agglutination 
easily visualized by TEM (Figure 1.12). 
 Because of their optical properties, QDs have also been widely used as 
fluorescent probes in biology. Fang et al. recently reported the use of β-N-
acetylglucosamine (GlcNAc)- and mannose-conjugated QDs to observe the 
different distributions of the GlcNAc and mannose receptors on the surfaces of 
sperms obtained from mice, pig, and sea-urchins. Confocal microscopy images 
showed that GlcNAc-conjugated QDs bound to the head of the sperm, while those 
with mannose moieties spread over the whole sperm body.71 
 
 Carbohydrate-conjugated nanoparticles in bio-detaction. The aggregation 
of noble metal nanoparticles induced by specific bioaffinity reactions has been 
exploited as a practical tool for the development of colorimetric detection of DNA 
hybridization, immunoassays, and the controlled assembly of nanoparticles. 
Geddes et al.72 reported an approach to glucose sensing by using high-molecular-
weight dextran-conjugated gold nanoparticles, which is based on the aggregation 
and disassociation of 20-nm gold particles and the changes in plasmon absorption 
induced by the presence of glucose.  
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 Lin et al.73 demonstrated the feasibility of carbohydrate-functionalized 
nanoparticles for the simultaneous enrichment and isolation of target proteins 
from a mixture at the femtomole level. The analytical scheme is illustrated in 
Figure 1.13. The target proteins were captured by the carbohydrate-conjugated 
nanoparticles through the specific carbohydrate-protein interactions and directly 
analyzed by MALDI-TOF MS. 
 
 Carbohydrate-conjugated nanoparticles in therapeutic applications. With 
a grater understanding of the importance of carbohydrate-protein interactions in 
microbiological contexts, researchers began to investigate the feasibility of 
antiadhesion therapy,74 which is based on the following scientific hypotheses and 
research findings: (1) microbial infection is initiated by the adhesion of the 
microorganism to the host tissue; (2) adhesion is mediated through the 
interactions between microbial surface adhesins and carbohydrate receptors on the 
host cell surface; and (3) microbial adhesion can be inhibited by carbhohydrates. 
Therefore, it is reasonable to use carbohydrates to block their counterpart proteins 
to prevent the adhesion process. Several soluble natural and synthetic 
carbohydrates have been used in anti-adhesion treatments against bacteria. 
Among the very few papers reporting the use of carbohydrate-conjugated 
nanoparticles for this purpose, Penades et al. prepared lactose-conjugated gold 
nanoparticles as an antiadhesive tool in tumoral metastasis progression in vivo. It 
was demonstrated that specific tumor-associated carbohydrate antigens 
(glycosphingolipids and glycoproteins) are involved in the initial step of tumor 
  27
spreading. Using a mouse melanoma model, the authors showed that these 
lactose-conjugated nanoparticles can reduce the progression of experimental 
metastasis, indicating the potential of this glyconanotechnology for use in other 
anti-adhesion therapies (Figure 1.14).75 
 In summary, this chapter reviewed current best practices regarding the 
synthesis and applications of carbohydrate-conjugated nanoparticles. Although 
much progress has been made in the synthetic methodologies of carbohydrate-
conjugate nanoparticles, their applications are still in their infancy. 
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Figure 1.12 Lower magnification (a, b) and higher magnification (c, d) 
TEM images (dark field) showing the agglutination of E. coli ORN178 
mediated by D-mannose tethered polymeric nanoparticles. (From Ref. 
[54].) 
2 µm 
b 
500 nm 
2 µm 
a 
500 nm 
d c 
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Figure 1.13 The analytical scheme of the NBAMS technique for the 
specific capture of target proteins and the rapid mapping of binding-
epitope-containing peptides. 
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Figure 1.14 Schematic representation of the experimental design for the 
evaluation of the antimetastatic potential of lacto-GNPs. Control group C 
(mice inoculated only with lacto-GNPs in Hank's solution) is not 
represented. (From Ref. [75].) 
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CHAPTER 2 
GALACTOSYLATED AND MANNOSYLATED POLYMERIC 
NANOPARTICLES: SYNTHESIS, CHARACTERIZATION, AND 
APPLICATIONS 
 
2.1 Introduction 
 It has been established in the literature that carbohydrates serve as recognition 
molecules in the adhesion of bacteria to host cells via carbohydrate-protein 
interaction.1,2,3 For example, the attachment of enteropathogens such as 
Escherichia coli to epithelial cells is mediated by mannose-specific adhesins on 
the surface of these organisms, which bind to mannose or mannose-like receptors 
on the mucosal cell.4-10 There have been considerable scientific interests in an 
understanding and mimicking of the bacterial adhesin-receptor interactions for 
various purposes, including pathogen detection and treatment of bacterial 
infections.2,11-15 However, carbohydrate-protein interactions are generally weak, 
which in nature are enhanced by the presentation of multiple carbohydrate ligands 
to individual receptors.16-18  In the study of adhesions with bacterial cells, linear 
polymers and other two- and three-dimensional species bearing multiple mannose 
molecules have been developed and used to facilitate the required multivalence 
binding.16-23  
  Microspheres or beads have been widely used in biological and medical 
assays.24 However, their relatively large sizes are disadvantageous in some 
  38
applications, such as in the capturing of bacterial cells in immunoseparations.25 
Recently, nanoscale particles have been developed and studied as novel or 
improved carriers for bioactive functionalities.26-33 For examples, nanoscale gold 
particles coated with tethered mannose molecules were shown to selectively bind 
to type 1 pili in E. coli.29 It was suggested that the strong and selective binding 
presents a novel method of labelling specific protein on the cell surface using 
carbohydrate conjugated nanoparticles and that a significant advantage with the 
use of nanoparticles is to allow relatively easy and direct detection of the target 
receptors on the cell surface under an electron microscope.29 Similarly, lactose-
conjugated gold nanoparticles were found to exhibit selective aggregation when 
exposed to Recinus communis agglutinin, accompanied by significant color 
changes for optical detection.30 In other related reports, Mumper and coworkers 
showed that the macrophage cell uptake and binding of mannan-coated cationic 
nanoparticles were indeed mannose receptor-mediated.32 Gu et al. demonstrated 
that magnetic FePt nanoparticles with multiple antibiotic units could be used to 
detect E. coli at a very low concentration level.33 
 Polymeric nanoparticles can be prepared conveniently in sizes on the order of 
100 nm, which are between those of microspheres and gold nanoparticles.28,31  
The particles can be tethered covalently with the desired bioactive groups or 
biological species, providing a versatile and robust platform in the design of 
specific nanoscale sensors or delivery vehicles for various purposes.  
 In this work, we synthetically prepared polymeric nanoparticles that are 
covalently functionalized with derivatized galactose molecules (Part I) and D-
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mannose molecules (Part II) through dispersion polymerization (Scheme 2.1). 
These galactosylated and mannosylated nanoparticles are much larger in size than 
those based on the nanoscale gold particles, thus bearing considerably more 
surface-tethered mannose moieties. There are strong adhesin-specific interactions 
of the nanoparticles with E. coli cells.  Since a single nanoparticle is capable of 
binding more than one cell, the adhesion interactions result in significant 
nanoparticles-mediated cell agglutinations, which can easily be visualized in 
terms of electron microscopy imaging. 
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2.2 Galactosylated Polymeric Nanoparticles 
 
2.2.1 Experimental Section 
 Materials. β-D-Galactosepentaacetate, p-chloromethylstyrene (90%), 2-
chloroethanol, 4-dimethylaminopyridine (DMAP, 99%), hydrochloric acid, N-
hydroxysuccinimide (93+%), MES hydrate (99%), pyridine (99%), sodium 
hydride (60%, dispersed in mineral oil), sodium bicarbonate (powder), palladium 
on activated carbon (10% Pd), and succinic anhydride (99%) were purchased 
from Acros, azobis(isobutyronitrile) (AIBN, 98%) was from Aldrich, N,N’-
dicyclohexylcarbodiimide, triphenylphosphine (99%), sodium azide (99%), and p-
toluenesulfonyl chloride (98%) were from Alfa Aesar, styrene was from Baker, 
polyethylene glycol (PEG, MW ~ 2000) was from Fluka, tetrabutylammonium 
iodide (98%) was from Lancaster, and ethanol, chloroform, methylene chloride, 
THF, DMF, and diethyl ether were from Fisher. THF and methylene chloride 
were distilled over sodium and calcium hydride, respectively, and DMF was dried 
with calcium hydride and distilled under reduced pressure before use. Deuterium 
oxide (99.9%) and deuterated chloroform for NMR measurements were supplied 
by Cambridge Isotope Laboratories. Cellulose membrane tubing for dialysis was 
obtained from Sigma. 
 Measurements. NMR measurements were performed on a JEOL Eclipse 
+500 NMR spectrometer. Dynamic light scattering characterization was carried 
out on a Coulter N4 Plus particle sizer. Transmission electron microscopy (TEM) 
analyses were conducted on an Hitachi HD-2000 TEM/STEM system equipped 
with a CCD camera for digital imaging. 
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 Synthesis of galactosylated nanoparticles. The galactosylated nanoparticles 
were prepared via copolymerization of galactosylated macromonomer with 
styrene. Galactosylated macromonomer was synthesized in terms of the 
procedures shown in Scheme 2.2, Scheme 2.3, and Scheme 2.4. 
 ω-Hydroxy-St-PEG macromonomer 1.  NaH (~60%, 0.6 g, 15 mmol) was 
added to a solution of polyethylene glycol (Mw ~ 2000, 20 g, 10 mmol) in THF 
(100 mL). After being kept at 40 °C for 4 h, the reaction mixture was cooled to 34 
°C, added with p-chloromethylstyrene (1.83 g, 12 mmol), kept at 30 °C for 24 h, 
and then neutralized with diluted HCl. Sodium chloride was removed by 
filtration. The resulting solution was concentrated and precipitated into cold ether, 
followed by filtration for the solids and drying in a vacuum oven at room 
temperature to obtain macromonomer 1 (20.1 g, 95% yield). 1H NMR (500 MHz, 
CDCl3):  * 7.38 (d, J = 7.30 Hz, 2H), 7.30 (d, J = 6.9 Hz, 2H), 6.72 (m, 1H), 5.74 
(d, J = 17.85 Hz, 1H), 5.24, (d, J = 10.55 Hz, 1H), 4.65 (s, 2H), 3.4-4.0 (m, 180H) 
ppm; 13C NMR (125 MHz, CDCl3): * 137.95, 136.99, 136.60, 128.01, 126.26, 
113.82, 73.00, 72.60, 70.41, 69.45, 61.78 ppm. 
 ω-Tosylate-St-PEG macromonomer 2.  Macromonomer 1 (10 g, 4.3 mmol) 
was dissolved in dry CH2Cl2, followed by the addition of pyridine (5.2 g, 65 
mmol). The mixture was cooled to 0 °C, and then p-toluenesulfonyl chloride 
(12.65 g, 65 mmol) was added. The resulting mixture was stirred at room 
temperature for 12 h. After CH2Cl2 was removed on a rotary evaporator, to the 
resulting oil were added CHCl3 (20 mL) and H2O (10 mL). The organic layer was 
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Scheme 2.2 Synthesis of macronomer 5. 
Cl
HO O OH
46 p-Totuenesulfonyl chloride
NaN3
Tetrabutyl iodide
triphenyl phosphine/H2OSuccinic anhydride
O
N3
46O
NH
O
OH
O
46 O
NH2
46
O
OS
O
O46O
OH
46
45
21
3
  44
 
AcO
O
OAcAcO
OAc
OAc
AcO
O
OAcO
OAc
OAc Cl
AcO
O
OAcO
OAc
OAc
N3
O
HO
OH
OH
HO
O
N3
O
HO
OH
OH
HO
O
NH2
HOCH2CH2Cl
BF3.Et2O
NaN3
MeONa
H2/Pd-C
9 8
76
Scheme 2.3 Synthesis 2-aminoethyl-α-D-galactopyranoside 9. 
 
  45
 
46O
NH
OH
O
O
OH
HO O
OH
OH
H2N
O
46
OH
HO O
OH
OH
NH
O
O
NH
O
O
N-hydroxysuccinimide
N,N'-dicyclohexylcarbodiimide
46
N
O
O
O
NH
O
O
O
10 
9 
10a 5 
Scheme 2.4 Synthesis of galactosylated macromonomer 10. 
  46
 washed with HCl (2 M), aqueous NaHCO3 (5%), and then H2O.  It was dried 
with MgSO4 powder, filtered, and precipitated into cold ether. After washed with 
cold ether several times, it was dried in a vacuum oven at room temperature 
overnight to obtain macromonomer 2 (9.5 g, 92% yield). 1H NMR (500 MHz, 
CDCl3):  * 7.78 (d, J = 8.25 Hz, 2H), 7.25-7.44 (m, 6H), 6.69 (m, 1H), 5.72 (d, J 
= 17.85 Hz, 1H), 5.22 (d, J = 11.0 Hz, 1H), 4.55 (s, 2H), 4.15 (t, J = 4.80 Hz, 2H), 
3.40-3.80 (m, 180 H), 2.44 (s, 3H) ppm; 13C NMR (125 MHz, CDCl3): * 144.83, 
137.95, 136.96, 136.59, 133.04, 129.89, 128.03, 127.99, 126.25, 113.81, 72.97, 
70.88, 70.78, 70.69, 70.61, 69.44, 69.30, 68.71, 21.71 ppm. 
 ω-Azide-St-PEG macromonomer 3.  Macromonomer 2 (8.9 g, 4.2 mmol) 
was dissolved in DMF (60 mL), and to the solution was added NaN3 (2.76 g, 42 
mmol) and tetrabutylammonium iodide (0.2 g, 0.54 mmol). After being kept at 40 
°C for 4 h, the mixture was precipitated into cold ether to remove DMF. The 
resulting solids were re-dissolved in CHCl3, and the solution was dried with 
MgSO4. Upon filtration to remove MgSO4, the CHCl3 solution was concentrated 
and again precipitated into cold ether, followed by the filtration again and drying 
in a vacuum oven at room temperature to obtain macromonomer 3 (8.3 g, 95% 
yield). 1H NMR (500 MHz, CDCl3): * 7.38 (d, J = 8.25 Hz, 2H), 7.30 (d, J = 7.35 
Hz, 2H), 6.70 (m, 1H), 5.73 (d, J = 16.55 Hz, 1H), 5.23 (d, J = 11.0 Hz, 1H), 4.54 
(s, 2H), 3.80-3.54 (m, 180 H), 3.38 (t, J = 5.05 Hz, 2H) ppm; 13C NMR (125 
MHz, CDCl3): * 137.95, 137.00, 136.60, 128.00, 126.26, 113.82, 73.00, 70.70, 
70.63, 69.45, 50.70 ppm. 
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 ω-Amine-St-PEG macromonomer 4.  Macromonomer 3 (3 g, 1.38 mmol), 
PPh3 (0.44 g, 1.65 mmol), and H2O (37.3 mg, 2.1 mmol) were dissolved in THF 
(25 mL), and the mixture was stirred at room temperature for 36 h. The reaction 
mixture was concentrated and precipitated into cold ether, followed by filtration 
for the solids and drying under vacuum at room temperature to obtain 
macromonomer 4 (2.6 g, 94% yield).  1H NMR (500 MHz, CDCl3): * 7.39 (d, J = 
8.25 Hz, 2H), 7.30 (d, J = 8.20 Hz, 2H), 6.71 (m, 1H), 5.74 (d, J = 18.30 Hz, 1H), 
5.23 (d, J = 11.45 Hz, 1H), 4.56 (s, 2H), 3.8-3.4 (m, 180H), 2.88 (t, J = 5.25 Hz, 
2H) ppm; 13C NMR (125 MHz, CDCl3): * 137.94, 136.97, 136.59, 127.99, 
126.25, 113.81, 73.10, 72.98, 70.70, 70.61, 70.33, 69.43, 41.84 ppm. 
 ω-Carboxyl-St-PEG macromonomer 5.  Macromonomer 4 (1.96 g, 9.2 
mmol), succinic anhydride (1.85 g, 18.4 mmol), and DMAP (10 mg, 0.08 mmol) 
were dissolved in CH2Cl2 (20 mL), and the solution was stirred at room 
temperature for 36 h. Water (5 mL) was added to quench the reaction. The 
solution was washed with water (5 mL x 3), and the organic layer was dried with 
MgSO4 and filtered. The resulting solution was concentrated and precipitated into 
cold ether, followed by filtration for the solids and drying under vacuum at room 
temperature to obtain macromonomer 5 (1.63 g, 80% yield). 1H NMR (500 MHz, 
CDCl3): * 7.40 (d, J = 8.21 Hz, 2H), 7.34 (d, J = 7.80 Hz, 2H), 6.27 (m, 1H), 5.76 
(d, J = 18.35 Hz, 1H), 5.24 (d, J = 10.1 Hz, 1H), 4.58 (s, 2H), 3.90-3.40 (m, 
180H), 2.67 (t, J = 6.65 Hz, 2H), 2.56 (t, J = 6.62 Hz, 2H) ppm; 13C NMR (125 
MHz, CDCl3): * 174.26, 172.67, 137.92, 136.97, 136.58, 128.00, 126.26, 113.83, 
73.00, 72.00-70.3(m), 70.25, 69.65, 69.42, 39.51, 31.03, 30.27 ppm.  
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 2-Chroloethyl-2,3,4,6-tetra-O-acetyl-galactopyranoside 6. To a cold 
solution (0 ºC ) of β-D-galactose-pentaacetate (7.8 g, 20 mmol) and 2-
chloroethanol (1.93g, 24 mmol) in dry CH2Cl2 was added BF3.OEt2 (48% Et2O 
solution, 15ml, 120mmol) dropwise. Stirring was continued for 1 h at 0 °C, then 
at room temperature (12 h). The mixture was washed with cold water (10 mL * 
3), aqueous sodium hydrogencarbonate (5%, 10 mL), cold water (10 mL). The 
organic phase was dried over anhydrous MgSO4. After filtration, the solvent was 
removed on a rotary evaporator. Purification by column chromatography on silica 
gel using ethyl acetate : hexane (1:1) as eluent to afford 6  as a colorless solid 
(7.5g , 91%). 1H NMR (500 MHz, CDCl3): δ 5.39 (d, 1H), 5.22 (q, 1H), 5.02 (dd, 
1H), 4.53 (d, 1H), 4.20-4.16 (m, 1H), 4.15-4.09 (m, 2H), 3.91 (t, 1H), 3.78-3.73 
(m, 1H), 3.64-3.61 (t, 2H), 2.15 (s, 3H),  2.07 (s, 3H),  2.05 (s, 3H),  1.98 (s, 3H); 
13C NMR (125 MHz, CDCl3): δ 170.51, 170.32, 170.26, 169.68, 101.75, 70.87, 
70.81, 70.05, 68.62, 67.02, 61.34, 42.64, 20.89, 20.79, 20.77, 20.69. MALDI: 
433.88 (M+Na) +.  
 2-Azidoethyl-2,3,4,6-tetra-O-acetyl-galactopyranoside 7. Sodium azide 
(5.6g, 80 mmol) was added to a mixture of 6 (7.5g, 18 mmol) and 18-crown-6 
(100 mg) in DMF (30ml). The system was kept at 65 ºC for 24 h. Water (60ml) 
and toluene (120ml) were added, organic layer was dried and concentrated, then 
followed by column chromatography on silica gel with the eluent of ethyl acetate 
: hexane (1:1.5) to give 7 (6.5 g,  86% ). 1H NMR (500 MHz, CDCl3): δ 5.37 (dd, 
1H), 5.23-5.19 (t, 1H), 5.01-4.99 (dd, 1H), 4.53 (d, 1H), 4.19-4.09 (m, 2H), 4.04-
4.00 (m, 1H), 3.92-3.88 (m, 1H), 3.70-3.64 (m, 1H), 3.51-3.45 (m, 1H),  3.30-3.25 
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(m, 1H), 2.13 (s, 3H),  2.04 (s, 3H),  2.02 (s, 3H), 1.95 (s,3H); 13C NMR (125 
MHz, CDCl3): δ 170.48, 170.32, 170.23, 169.57, 101.21, 70.97, 70.87, 68.59, 
68.49, 67.07, 61.33, 50.63, 20.85, 20.74 (2C), 20.65. MALDI: 438.85 (M+Na) +.  
 2-Azidoethyl-D-galactopyranoside 8. Compound 7 (2.085 g, 5mmol) was 
dissolved in 200 mL NaOCH3 (0.1 M) and stirred at room temperature for 24 h. 
After concentration, the resulting residue was dissolved in water (50 mL) and then 
neutralized by Amberlite resin. The solvent was removed on a rotary evaporator 
to give 8 quantitatively. 1H NMR (500 MHz, CD3OD): δ 4.27-4.25 (dd, 1H), 
4.04-3.99 (m, 1H), 3.83-3.81 (dd, 1H), 3.78-3.69 (m, 3H), 3.52 (m, 2H), 3.47 (m, 
3H); 13C NMR (125 MHz, CD3OD): δ 105.17, 76.82, 75.00, 72.50, 70.35, 69.27, 
62.55, 52.15. MALDI: 272.73 (M+Na) +.  
 2-Aminoethyl-D-galactopyranoside 9. Pd-C (200 mg) was added to a 
solution of 8 (2.085 g, 4 mmol) in water (20 mL), and the mixture was stirred at 
room temperature for 24 h under hydrogen atmosphere. After filtration, water was 
removed on a rotary evaporator to give 9 as syrup quantitatively. 1H NMR (500 
MHz, D2O): δ 4.39 (d, 1H), 3.98-3.94 (m, 1H), 3.90 (d, 1H), 3.78-3.72 (m, 3H), 
3.70-3.65 (m, 1H), 3.64-3.60 (dd, 1H), 3.54 -3.49 (dd, 1H), 2.86-2.82 (m, 2H); 
13C NMR (125 MHz, D2O): δ 103.04, 75.32, 72.82,70.96, 70.17, 68.77, 61.14, 
40.15. MALDI (M+Na)+: 244.59 (Cal. 246). 
 Galactosylated macromonomer 10. Galactosylated macromonomer was 
prepared via the classical carbodiimide-activated coupling of 5 and 9 (Scheme 
2.4).  In the reaction, to a cold solution of 5 (0.5 g, 0.226 mmol) and N-
hydroxysuccinimide (28.6 mg, 0.249 mmol) in methylene chloride (10 mL) was 
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added N,N’-dicyclohexylcarbodiimide (56 mg, 0.271  mmol), and the mixture 
was reacted at 0 °C for 10 h. The reaction mixture was filtered, concentrated on a 
rotary evaporator, and precipitated into cold diethyl ether. The precipitation 
process was repeated twice to obtain 10a.  
 To the solution of 10a in DMF (10 mL) was added 9 (46.3 mg, 0.208 mmol), 
and the mixture was reacted at room temperature for 24 h. Then, the reaction 
mixture in a cellulose membrane tubing (cut-off molecular weight ~ 500) was 
dialyzed against fresh deionized water for 48 h to obtain 10 (70% yield). 1H NMR 
(500 MHz, CDCl3): δ 7.37 (d, J = 8.2 Hz, 2H), 7.29 (d, J = 8.2 Hz, 2H), 6.69 (m, 
1H), 5.73 (d, J = 17.8 Hz, 1H), 5.22 (d, J = 11.4 Hz, 1H), 4.54 (s, 2H), 5.26 (d, J = 
6.9 Hz), 4.00-3.20 (m), 2.56 (m, 4H) ppm; 13C NMR (125 MHz, CDCl3): δ 
174.95, 174.91, 137.94, 137.01, 136.61, 128.04, 126.29, 113.85, 103.67.  
 Galactosylated nanoparticles. The dispersion copolymerization shown in 
Scheme 2.1 was used to prepare the nanoparticles with a polystyrene core and 
surface PEG tethers,34 which are terminated with galactose moieties. In a typical 
co-polymerization reaction, the macromonomer 10 (0.62 g, 0.26 mmol), styrene 
(0.55 g, 5.3 mmol), and the polymerization initiator AIBN (9 mg, 0.055 mmol) 
were mixed in ethanol-water mixture (4/1 v/v, 5 mL) in a round flask. Upon 
degassing via freeze-thaw cycles, the flask was sealed, and the mixture was stirred 
at 60 oC for 24 h to form the nanoparticles. The suspended nanoparticles were 
transferred to a cellulose membrane tubing (cut-off molecular weight ~ 12,000) 
for dialysis against fresh deionized water for 3 days. 
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 Experiments with E. coli. The E. coli O157: H7 strain EDL931 was obtained 
from Centers for Disease Control and Prevention. The E. coli ORN178 was kindly 
provided by Prof. Chun-Cheng Lin of National Taiwan Normal University.29 The 
frozen E. coli samples were recovered and cultured in trypticase soy broth. After 
overnight incubation at 37 °C, the bacterial culture was harvested and 
resuspended in sterile phosphate bufferred saline (PBS, pH 7.4). In a typical 
experiment for cell adhesion, the galactosylated polymeric nanoparticles were 
suspended in PBS. An aliquot of the suspension was mixed with the E. coli 
suspension in PBS for 15 min. The mixture was centrifuged at 8000 g for 5 min, 
which resulted in the precipitation of the bacterial cells with any adherent 
nanoparticles, while the unbound nanoparticles remained in solution. The 
supernatant containing free nanoparticles was discarded, and the pellet was 
washed twice with PBS in suspending–centrifuging cycles. The binding of the 
galactosylated polymeric nanoparticles with E. coli cells was probed by using 
TEM. The sample for the preparation of the TEM specimen was fixed in 
cacodylate buffered glutaraldehyde (3.5%, pH ~7.2) at 4 °C for 12 h. A droplet of 
the sample was deposited onto a carbon-coated copper grid, stained with uranyl 
acetate, and dried in air for 30 min. 
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2.2.2 Results and Discussion 
 
 Nanoparticle characterization. The galactosylated polymeric nanoparticles 
were in a stable aqueous suspension following the dialysis as the final step of the 
preparation process. The suspension appeared milky at the original high 
concentration but became optically more transparent upon dilution.  
 Dynamic light scattering (DLS) was used to characterize the nanoparticles in 
aqueous suspension. Shown in Figure 2.1 is the DLS result on the particles. The 
average diameter of the galactosylated polymeric nanoparticles is around 200 nm, 
with a relatively narrow size distribution standard deviation of 16 nm. Since the 
DLS measurement was in aqueous suspension, the particle size thus determined 
also includes the PEG corona over the polystyrene core (Scheme 2.1). On the 
other hand, the dried nanoparticles on a carbon-coated copper grid were analyzed 
by SEM. The specimen was prepared by depositing a small drop of the diluted 
particle suspension onto the grid, followed by evaporation to remove water. A 
typical SEM image of the galactosylated polymeric nanoparticles is shown in 
Figure 2.2. By counting the particles on the surface layer in SEM images, the 
average particle size and size distribution standard deviation are 178 and 14 nm, 
respectively. It is reasonable that the average particle size estimated from SEM is 
somewhat smaller than that from DLS measurement, because the PEG corona is 
likely shrunken under the conditions for SEM imaging.  
 The galactosylated polymeric nanoparticles were characterized by several 
NMR methods. In these nanoparticles, the particle core is made essentially of
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Size (nm) 
Figure 2.1 Dynamic light scattering result of the 
galactosylated polymeric nanoparticles in an aqueous 
suspension. 
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400 nm
Figure 2.2 A typical SEM image of the galactosylated 
polymeric nanoparticles. 
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linear polystyrene polymers, and the tethered galactoses are pendant functional 
groups on the polymers. Thus, the nanoparticles can be dissolved in a solvent 
good for both the polystyrene backbones and the pendant galactose moieties, 
resulting in a homogeneous solution. Chloroform is such a solvent, so that NMR 
measurement was carried out in deuterated chloroform solution. As compared 
with that of the macromonomer before polymerization in Figure 2.3, the proton 
NMR spectrum of the dissolved nanoparticles is considerably broader (due to 
much lower mobility of the polymer chain), with characteristic polystyrene peaks 
in 7.2 – 6.1 and 2.3 – 1.2 ppm regions. The PEG signal remains at ~3.65 ppm. 
However, the relative concentration of the tethered galactoses is too low to be 
detected in the NMR measurement of the nanoparticles in the homogeneous 
chloroform solution. According to 1H NMR signal integrations for the PEG and 
styrene peaks, the macromonomer mole fraction in the copolymer is on the order 
of 5%. 
 Gel-phase NMR was employed to analyze the nanoparticle-bound galactose 
moieties. For the measurement, the nanoparticles were suspended in deuterated 
water. Under such a condition, the polystyrene core was in the solid state, thus 
contributing no NMR signals.35 Only the hydrophilic tethers and the galactoses 
could be detected. The gel-phase proton NMR spectrum of the galactosylated 
polymeric nanoparticles is also compared in Figure 2.3. It exhibits no signals from 
the polystyrene core, as predicted. The PEG signal at 3.65 ppm is strong and 
broad, covering the expected peaks from the tethered galactoses. However, the 
overlapping between the PEG and galactose signals is less significant in the gel-
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02468
Macromonomer 
Solution NMR 
Gel phase NMR 
Chemical Shift 
Figure 2.3 1H NMR spectra of the galactosylated macromonomer (top) and 
the galactosylated polymeric nanoparticles in a homogeneous CDCl3 
solution (middle) and in D2O (gel phase NMR, bottom). 
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phase 13C NMR spectrum. The peaks due to the tethers at 174 ppm (carbonyl), 39 
ppm (-CH2NH-), and 32 ppm (-COCH2CH2CO-) and the galactose carbons at 103 
and 62 ppm could be clearly identified. Other galactose carbon signals are still 
mixed up with those from the PEG moieties. Nevertheless, the NMR results are 
consistent with the nanoparticle structure of a polystyrene core and flexible 
surface tethers terminated with galactoses. 
 Quantification of nanoparticle-bound galactoses. The amount of tethered 
galactoses in the nanoparticles was estimated by using the classical anthron-
sulfuric acid method, which is widely employed in the determination of sugar 
content in an analyte based on the oxidation of sugar moieties.28a In the test, the 
nanoparticle-bound galactoses were oxidized in an aqueous H2SO4-HCl-formic 
acid solution of anthron at 100 °C. The absorbance at 625.5 nm was used for the 
quantification in reference to a standard curve. A technical difficulty in the 
measurement was due to the scattering effect of the nanoparticle suspension. To 
compensate the scattering effect, a suspension of the polymeric nanoparticles 
containing no galactoses, but with comparable total particle counts, was used as 
the blank. The galactose content in the nanoparticle sample was estimated to be 
6.5% (wt/wt). On the other hand, the macromonomer mole fraction in the 
copolymer estimated above in terms of solution-phase 1H NMR signal 
integrations puts the galactose content on the order of 4.3% (wt/wt). By using the 
average particle diameter from the SEM analysis for the spherical polystyrene 
core, with the assumption that the core has the same density as bulk polystyrene 
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(1.047 g/cm3), these galactose content values suggest that there are on average 0.8 
– 1.3 million tethered galactoses on each particle. 
 Cell adhesion. The bioactivities of the galactosylated polymeric nanoparticles 
were evaluated in terms of their adhesion to several E. coli strains. For the 
pathogenic E. coli O157: H7, as an example, the bacterial cells in PBS were 
mixed with the suspended nanoparticles, followed by centrifuging to separate the 
cells from free nanoparticles in the supernatant. The pellet was washed repeatedly 
with PBS through a suspending –centrifuging routine. The interactions of the 
galactosylated polymeric nanoparticles with E. coli O157: H7 cells were 
visualized in TEM analyses. Shown in Figure 2.4 is a typical TEM image of the 
sample. The galactosylated polymeric nanoparticles are apparently bioactive, 
binding with multiple E. coli cells to result in significant cell agglutination. This 
is consistent with the report that there are periplasmic galactose-binding proteins 
on the E. coli cell that couple with galactose ligands.36 
 The E. coli ORN178 strain is known to contain receptors toward D-
mannoses.29 Interestingly, however, the galactosylated polymeric nanoparticles 
can also bind with E. coli ORN178. The TEM image in Figure 2.5 shows that an 
E. coli cell is surrounded by a large number of the nanoparticles. This could not 
be a result of simple adsorption because no binding was observed with the use of 
bare polymeric nanoparticles without the galactose moieties.  
 Multivalent carbohydrate ligands carried on linear and branched polymers 
ordendrimers are more potent than their monovalent counterparts in cell 
adhesion.12,17,28,37-41 The results reported here show that polymeric nanoparticles 
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are also very effective in the display of multivalent ligands for interactions with 
specific cell adhesions. The nanoparticles are easily imaged in microscopy 
analyses, allowing the visualization of the interactions. In addition, the polymeric 
nanoparticles displaying galactoses and other bioactive ligands may also be 
developed as potent inhibitors or effectors for specific cellular responses. 
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400 nm 
Figure 2.4 A TEM image showing the agglutination of E. coli 
O157:H7 cells mediated by the galactosylated polymeric 
nanoparticles. 
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400 nm 
Figure 2.5 A TEM image showing an E. coli ORN178 cell bound by 
many galactosylated polymeric nanoparticles. 
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 2.3 Mannosylated Polymeric Nanoparticles 
 
2.3.1 Experimental Section 
 Materials. D-mannose was obtained from Alfa Aesar. All the others are the 
same as those in Part I of this Chapter. Mannosylated macromonomer was 
synthesized in terms of  procedures shown in Scheme 2.2, Scheme 2.5, and 
Scheme 2.6. 
 1,2,3,4,6-Penta-O-acetyl mannopyranoside 11. A solution of D-mannose 
(15.0 g, 83.3 mmol) in anhydrous pyridine (70 mL) was placed in an ice bath, 
followed by dropwise addition of acetic anhydride (100 mL, 1058.8 mmol). 
Stirring was continued for 1 h at 0 °C, then at room temperature (12 h). Pyridine 
and excessive acetic anhydride were removed on a rotary evaporator and 
chloroform (70 mL) was added. The mixture was washed with cold water (10 
mL*3), aqueous sodium hydrogencarbonate (5%, 10 mL), cold water (10 mL). 
The organic phase was dried over anhydrous MgSO4. After filtration, the solvent 
was removed on a rotary evaporator to give compound 11 (29.2g, 90% yield). 1H 
NMR (500 MHz, CDCl3): * 2.0-2.3 (m, 15H), 4.0-4.2 (m, 2H), 4.2-4.4 (m, 1H), 
5.1-5.5 (m, 3H), 6.08 (d, J = 1.85 Hz, 1H) ppm; 13C NMR (125 MHz, CDCl3): 
* 20.00-22.00(m), 62.02, 65.44, 68.28, 68.71, 70.54, 90.53, 168.00, 169.65, 
169.69, 169.92, 170.55 ppm. 
 2-Chloroethyl 2,3,4,6-tetra-O-acetyl-D-mannopyranoside 12. To a cooled 
(ice-water), stirred solution of 11 (13.5 g, 34.6 mmol) and 2-chloroethanol (4.18 
g, 51.9 mmol) in anhydrous dichloromethane (60 mL) was added BF3-etherate (22
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Scheme 2.5 Synthesis 2-aminoethyl-α-D-mannopyranoside 15. 
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Scheme 2.6 Synthesis mannosylated macromonomer 16. 
 
5 16
a
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 mL, 173 mmol) dropwise. Stirring was continued for 1 h at 0 °C, then at room 
temperature (12 h). The mixture was worked up using the same procedure as 11 to 
give 12 (12.7g, 90% yield). 1H NMR (300 MHz, CDCl3): * 2.0-2.3 (m, 12H), 
3.70 (t, J = 5.54 Hz, 2H), 3.80-3.97 (m, 2H), 4.00-4.16 (m, 2H), 4.25-4.35 (m, 
1H), 4.89 (d, J = 1.42 Hz, 1H), 5.22-5.37 (m, 3H) ppm; 13C NMR (75 MHz, 
CDCl3): * 20.00-22.00(m), 42.40, 62.36, 65.95, 68.56, 68.87, 69.35, 97.75, 
169.69, 169.78, 169.92, 170.52 ppm. 
 2-Azidoethyl 2,3,4,6-tetra-O-acetyl-D-mannopyranoside 13. To a solution 
of 12 (12.7g, 30.9 mmol) and tetrabutylammonium bromide (0.2 g, 0.6 mmol) in 
DMF (50 mL) was added sodium azide (20 g, 309 mmol). The system was kept at 
65 °C for 12 h. DMF was removed on a rotary evaporator, and re-dissolved in 
chloroform (50 mL). The organic phase was washed by water (10 mL*3) and 
dried over anhydrous MgSO4. After filtration, the solvent was removed to give 13 
(12.6g, 98% yield). 1H NMR (500 MHz, CDCl3): * 1.9-2.3 (m, 12H), 3.47 (m, 
2H), 3.70 (m, 1H), 3.88 (m, 1H), 4.10 (m, 2H), 4.30 (m, 1H), 4.90 (d, J = 1.41 Hz, 
1H), 5.28-5.40 (m, 3H) ppm; 13C NMR (125 MHz, CDCl3): * 20.00-22.00 (m), 
50.37, 62.47, 65.97, 67.08, 68.84, 68.89, 69.38,  97.74, 169.82, 169.88, 169.96, 
170.69 ppm. 
 2-Azidoethyl-D-mannopyranoside 14. Compound 13 (5.0 g, 12 mmol) was 
dissolved in 500 mL NaOCH3 (0.1 M) and stirred at room temperature for 24 h. 
After concentration, the resulting residue was dissolved in water (100 mL) and 
then neutralized by Amberlite resin. The solvent was removed on a rotary 
evaporator to give 14 quantitatively. 1H NMR (500 MHz, D2O): * 3.40-3.56 (m, 
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2H), 3.60-3.78 (m, 4H), 3.80-3.83 (m, 1H), 3.84-3.93 (m, 2H), 3.95 (m, 1H), 4.89 
(d, J = 1.85 Hz, 1H) ppm; 13C NMR (125 MHz, D2O): * 50.35, 61.07, 66.46, 
66.84, 70.08, 70.54, 73.06, 99.97 ppm. 
 2-Aminoethyl -D-mannopyranoside 15. To a solution of 14 ( 5 g, 10 mmol) 
in water (50 mL), Pd-C ( 200 mg) was added, the mixture was degassed under 
vacuum with stirring, refilled with hydrogen, and stirred for 12 h. Pd-C was 
removed by filtration, and water was removed on a rotary evaporator to give 15 as 
a syrup quantitatively.  1H NMR (500 MHz, D2O): * 2.70-2.90 (m, 2H), 3.40-
4.00 (m, 8H), 4.86 (d, J = 1.04 Hz, 1H) ppm; 13C NMR (125 MHz, D2O): 
* 40.05, 61.10, 66.86, 68.84, 70.15, 70.66, 72.86, 100.08 ppm. 
 Mannosylated macromonomer 16. The macromonomer 16 was prepared via 
the classical carbodiimide-activated coupling of 5 and 15 (Scheme 2.6). In the 
coupling reaction, to a cold solution of 5 (0.5 g, 0.226 mmol) and N-
hydroxysuccinimide (0.0286 g, 0.249 mmol) in methylene chloride (10 mL) was 
added N,N’-dicyclohexylcarbodiimide (0.056 g, 0.271 mmol), and the mixture 
was reacted at 0 ºC for 10 h. The reaction mixture was filtered, concentrated on a 
rotary evaporator, and precipitated into cold diethyl ether. The precipitation 
process was repeated to obtain 16a (87% yield). 1H NMR (500 MHz, CDCl3): 
* 7.34 (d, J = 8.20 Hz, 2H), 7.26 (d, J = 7.22 Hz, 2H), 6.64 (m, 1H), 5.70 (d, J = 
18.30 Hz, 1H), 5.19 (d, J = 11.9 Hz, 1H), 4.50 (s, 2H), 3.3-3.90 (m), 2.93 (t, J = 
7.1 Hz, 2H), 2.78 (s, 4H), 2.56 (t, J = 7.32 Hz, 2H) ppm; 13C NMR (125 MHz, 
CDCl3): * 170.03, 169.09, 168.34, 137.94, 136.98, 136.60, 128.00, 126.26, 
113.83, 72.98, 68.00-72.00 (m), 39.48, 30.43, 26.76, 25.62 ppm. 
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 To a solution of 16a (0.4 g, 0.173 mmol) in DMF (10 mL) was added 15 
(0.0463 g, 0.208 mmol), and the mixture was reacted at room temperature for 24 
h. Then, the reaction mixture in a cellulose membrane tubing (cut-off molecular 
weight ~ 500) was dialyzed against fresh deionized water for 48 h to obtain 16 
(80% yield). 1H NMR (500 MHz, CDCl3): * 7.40 (d, J = 8.20 Hz, 2H), 7.34 (d, J 
= 7.80 Hz, 2H), 6.72 (m, 1H), 5.76 (d, J = 18.30 Hz, 1H), 5.26 (d, J = 11.9 Hz, 
1H), 4.58 (s, 2H), 3.40-3.90 (m, 180H), 2.67 (t, J = 7.30, 2H), 2.56 (t, J = 6.85 
Hz, 2H) ppm; 13C NMR (125 MHz, CDCl3): * 174.95, 174.91, 137.51, 137.20, 
136.47, 129.04, 126.58, 114.79, 99.85, 68-76 (m), 67.00, 66.00, 61.10, 39.11, 
31.22 ppm. 
 Mannosylated nanoparticles. In a typical reaction, the macromonomer 16 
(0.62 g, 0.26 mmol) and styrene (0.55 g, 5.3 mmol) were mixed with the 
polymerization initiator AIBN (9 mg, 0.055 mmol) and the ethanol-water mixture 
(4/1, 5 mL) in a round flask. Upon degassing via freeze-thaw cycles, the flask was 
sealed and the mixture was stirred at 60 oC for 24 h. The suspension of 
nanoparticles formed in the polymerization reaction was transferred to a cellulose 
membrane tubing (cut-off molecular weight ~ 12,000) for dialysis against fresh 
deionized water for 3 days. 
 E. coli samples. E. coli strains ORN178 and ORN208 were kindly provided 
by Dr. Chu-Cheng Lin, Institute of Chemistry, Academia Sinica, Taiwan.29 The 
two frozen E. coli samples were recovered and cultured in trypticase soy agar. 
After overnight incubation at 37 oC, the bacterial culture was harvested and 
suspended in phosphate buffer saline (PBS).  
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 Measurements. NMR measurements were performed on a JEOL Eclipse 
+500 NMR spectrometer.  Dynamic light scattering characterization was carried 
out on a Coulter N4 Plus particle sizer. Transmission electron microscopy (TEM) 
analyses were conducted on a Hitachi HD-2000 TEM/STEM system equipped 
with a CCD camera for digital imaging. 
 
2.3.2 Results and Discussion 
 The D-mannose functionalized nanoparticles (Scheme 2.7) were prepared in 
the dispersion copolymerization of the mannosylated macromonomer with 
styrene.34 The nanoparticles thus prepared form a stable suspension in water, 
which allows characterization by using the dynamic light scattering (DLS) 
technique. The DLS result shows that the suspended polymeric nanoparticles have 
an average diameter of ~160 nm. This is confirmed by the result from TEM 
imaging of the same sample deposited on a carbon-coated copper grid (Figure 
2.6). 
 In the study of adhesion interactions of the D-mannose functionalized 
polymeric nanoparticles with E. coli ORN178 (expressing wild-type 1 pili), the 
bacterial suspension in PBS was mixed with an aqueous suspension of the 
mannosylated nanoparticles for 5 min, and then the mixture was centrifuged at 
6,000 × g for 3 min. The supernatant containing free nanoparticles was removed, 
and the pellet was washed with PBS, centrifuged, and then re-suspended in PBS 
(1 mL). The sample for TEM imaging was fixed in cacodylate buffered 
glutaraldehyde (3.5%, pH ~ 7.2) at 4 oC for 12 h.  A droplet of the sample was 
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Scheme 2.7 Structure of mannosylated polymeric nanoparticles. 
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200 nm 
Figure 2.6 A TEM image of the mannosylated polymeric nanoparticles. 
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400 nm 
Figure 2.7 An E. coli ORN178 cell is bound a large number of the 
mannosylated polymeric nanoparticles. 
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deposited on a carbon-coated copper grid, stained with uranyl acetate, and then 
dried in air for 30 min. The TEM image in Figure 2.7 shows the binding of a large 
number of nanoparticles with an E. coli ORN178 cell.  The result suggests that the 
mannosylated polymeric nanoparticles have strong adhesion interactions with the 
E. coli strain. 
 The relative sizes of the nanoparticles to the bacterial cells and the large 
number of nanoparticle surface-tethered mannose functionalities enable some of 
the nanoparticles each bind with more than one E. coli cell.  As a result, there is 
significant agglutination of multiple E. coli cells. As shown in Figure 2.8, the 
agglutination mediated by the mannosylated polymeric nanoparticles is easily 
observed in the electron microscopy images. 
 The agglutination of E. coli ORN178 cells mediated by mannosylated 
nanoparticles was also visualized by SEM (Figure 2.9). Both the lower and higher 
magnification images clearly show the attachment of nanoparticles on the surfaces 
of E. coli cells. 
 The binding of the nanoparticles to E. coli cells and the resulting significant 
cell agglutination are associated with the specific adhesion interactions, for which 
the nanoparticle-bound D-mannose molecules are required.  In a control 
experiment, no agglutination was observed with the use of bare polymeric 
nanoparticles with the polyethylene glycol tethers but without the derivatized D-
mannose molecules (Scheme 2.7) under otherwise the same experimental 
conditions. The corresponding TEM image shows no meaningful difference from 
that of the suspended free E. coli ORN178 (Figure 2.10a). 
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d c 
Figure 2.8 Lower magnification (a,b) and higher magnification (c,d) TEM 
images (dark-field) showing the agglutination of E. coli ORN178 mediated by 
D-mannose-tethered polymeric nanoparticles. 
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600 nm 
1500 nm 
b 
a 
Figure 2.9 SEM images showing the agglutination of E. coli 
ORN178 mediated by mannosylated nanoparticles. (a) low 
magnification and (b) high magnification. 
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  3 µm 
3 µm 
a 
b 
Figure 2.10 (a) A TEM image of the specimen prepared from E. coli 
ORN178 suspended in PBS buffer. (b) A TEM image of the specimen from 
the experiment of E. coli ORN208 with D-mannose-tethered polymeric 
nanoparticles under the same experimental conditions as those for Figure 
2.8. 
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 The binding interactions responsible for the significant agglutination are also 
cell adhesin specific.  In another control experiment, E. coli ORN208 (deficient of 
the fimH gene and expressing abnormal type 1 pili without specific binding with 
D-mannose) instead of E. coli ORN178 was used for evaluation under the same 
experimental conditions.  The mannosylated polymeric nanoparticles hardly 
interact with this E. coli strain, resulting in no meaningful cell agglutination 
(Figure 2.10b). 
 The binding interactions of the mannosylated polymeric nanoparticles with E. 
coli ORN178 are strong.  In an experiment to compare the competitive binding 
abilities of the nanoparticle-tethered D-mannose moieties and the free D-mannose 
molecules to the E. coli cells, the mannosylated nanoparticles and a free D-
mannose solution (10 mg/mL) were incubated with the bacterial suspension. 
According to TEM analyses, there was significant binding of the nanoparticles to 
bacteria, with the same agglutination.  The results suggest that the nanoparticle-
bound D-mannose moieties are more competitive than free D-mannose molecules 
in the multivalent adhesion interactions with the E. coli cells. 
 Similarly, the agglutinated E. coli cells by the mannosylated polymeric 
nanoparticles could not be dissociated by a subsequent incubation with a solution 
of free D-mannose molecules (10 mg/mL).  In the literature, however, D-mannose 
solutions of comparable concentrations have been shown to inhibit the E. coli - 
yeast agglutination.6 
 The mannosylated polymeric nanoparticles are obviously effective in the 
agglutination of E. coli ORN178 via adhesin-specific interactions, and the 
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nanoparticles-mediated agglutination is conveniently detected in conventional 
electron microscopy. However, in addition to providing a unique platform for the 
visualization of the cell agglutination, the mannosylated polymeric nanoparticles 
may potentially serve as therapeutic agents for the inhibition of enteropathogenic 
infections.  It is known that the adherence of enterotoxigenic E. coli on intestinal 
epithelium is an important step in the infectious process. This adherence depends 
on binding between the bacterial specific adhesins (adhesive surface molecules on 
fimbria, pili or outer membranes) and the receptors (protein, glycoprotein, or 
glycolipid) on microvillous membranes of absorptive cells.4,5 It has also been 
shown that soluble D-mannose inhibits the adhesion of some enteropathogens to 
animal and human intestinal cells.6-10 With the strong adhesion interactions of the 
mannosylated polymeric nanoparticles with E. coli and the resulting significant 
cell agglutination, more effective inhibition might be expected from these 
nanoparticles. Further investigations on potential inhibition applications are 
planned. 
 
2.4 Conclusion 
 
 Polymeric nanoparticles of a polystyrene core and oligomeric PEG-based 
tethers can be prepared via dispersion copolymerization of styrene with 
specifically synthesized macromonomer. The tethers can be used to carry 
covalently derivatized galactose/mannose moieties, and the particle surface 
functionalities can be characterized by using NMR and other techniques. The 
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galactosylated and mannosylated polymeric nanoparticles are bioactive, 
exhibiting significant adhesion interactions with several E. coli strains. The 
reported work demonstrates that polymeric nanoparticles may serve as a versatile 
vehicle for the delivery or display of biofunctional groups in potential biological 
and biomedical applications.  
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CHAPTER 3 
POLY(ETHYLENE GLYCOL)-COATED MAGNETIC POLYMER 
NANOPARTICLES: SYNTHESIS, CHARACTERIZATION AND THEIR 
APPLICATIONS 
 
3.1 Introduction 
 Magnetic nanoparticles have received much attention in the past few years for 
their extensive use in such biomedical applications as target drug delivery,1 
magnetic resonance imaging (MRI),2 cell separation,3 immunoassays,4 nucleic 
acid purification,5 DNA separation,6 enzyme immunization.7 To satisfy these 
biomedical applications, magnetic nanoparticles must be able to fulfill certain 
criteria: no sedimentation, a uniform size and narrow size distribution, high and 
uniform magnetic content, superparamagnetic behavior, no iron leakage, 
biocompatibility, and high density of surface functional groups.8 
 Magnetic polymer nanoparticles (MPNPs), nanoparticles with external 
polymer shells, have generated much recent research efforts, because the 
methologies for the encapsulation of iron oxide nanoparticles in hydrophobic 
polymers is of fundamental interest, regarding the expansion of their use.9,10 A 
straightforward method for encapsulation involves the coating or encapsulation of 
magnetic nanoparticles with preformed natural or synthetic polymers either 
physically or chemically.11 MPNPs can also be obtained from the in situ 
precipitation of magnetic nanoparticles in the presence of polymer which acts as a 
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stabilizer. For example, Ugelstad and coworkers prepared monodisperse MPNPs 
by the precipitation of magnetic oxides inside preformed porous mono-sized 
polymer nanoparticles in situ.12,13 Many other processes developed for use in 
polymer encapsulation of magnetic nanoparticles include emulsion 
polymerization,14 seed polymerization,15 dispersion polymerization,16 suspension 
polymerization,17 atom transfer radical polymerization (ATRP),18,19 and 
miniemulsion polymerization.10,21,22 Among these processes, miniemulsion 
polymerization, which involves the encapsulation of inorganic particles into 
polymers, has been the focus of recent polymerization research.  
 In miniemulsion polymerization,23 miniemulsions are understood to be stable 
aqueous dispersions of monomer droplets with sizes of ~50-500 nm. These may 
be prepared by shearing a mixture of monomer, water, a surfactant, and a highly 
water insoluble compound - the so-called hydrophobe which is used to suppress 
Ostwald ripening of the droplets. Both the particle nucleation and propagation 
reaction occur primarily in these highly stable submicrometer monomer droplets, 
each of which may be viewed as individual nano-phase reactors. After 
polymerization, these droplets are polymerized without changing their identity. 
For successful encapsulation, the inorganic particles used are required to be 
hydrophobic for their preferable dispersion in hydrophobic monomer droplets. For 
example, following their report on the encapsulation of CaCO324 and carbon 
black25 into polystyrene particles, Landfester et al. similarly encapsulated high 
amounts of magnetite into the same polymer particles through a three-step 
preparation route which included two miniemulsion processes.8 In a somewhat 
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indirect approach, Gu et al.21 prepared a stable water-based dispersion of 
SDS/oleic acid bilayer coated magnetite aggregates for mixing with monomer 
styrene miniemulsion. MPNPs, with uniform magnetite encapsulation, were 
created by sonicating the mixture followed by polymerization. Recently, Forcada 
et al.22 also prepared MPNPs by miniemulsion polymerization of the oil-based 
styrene magnetite ferrofluid, using hexadecane as the hydrophobe, 2, 2’-
azobisisobutyronitrile as the initiator, sodium dodecyl sulfate as the emulsifier, 
and methacrylic acid as a comonomer. 
 There are several concerns that arise when using these as-produced MPNPs 
for biomedical applications.26,27 First, the surfactants may be physically adsorbed 
onto the MPNPs surfaces, resulting in their destabilization. Secondly, because of 
their large surface area/volume ratio, the MPNP surfaces are highly susceptible to 
non-specific plasma proteins adsorption. Thirdly, during the polymerization 
process, a large amount of functional groups became buried in the polymer with 
only a small part left on the surface. 
 Since surfaces covered with poly(ethylene glycol) (PEG) have proven to be 
nonimmunogenic, nonantigenic, and protein resistants,28 the introduction of PEG 
chains onto nanoparticle surfaces is obviously beneficial for use in biomedical 
applications because they have none of the disadvantages of the nanoparticles 
with such surface modifications.29 In the procedures detailed in this chapter, 
miniemulsion polymerization was applied to prepare hydrophilic MPNPs 
(Scheme 3.1) by using macromonomer 1 and 2 (Figure 3.1). These PEG-coated 
MPNPs were characterized using various instrumental techniques, such as NMR, 
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SEM, TEM, SQUID, TGA, at el. Our collaborators also detected L. 
monocytogenes in artificially contaminated milk, with the subsequent results 
suggesting that these MPNPs have more advantageous use in practical 
commercial applications than the commercially available Dynabeads currently in 
use.30a Furthermore, these PEG-coated MPNPs have been demonstrated to be as a 
good magnetic resonance imaging (MRI) agent as Ferumoxides injectable 
solution, the first liver-specific MRI enhancement agent.30b 
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Scheme 3.1 TEM picture of polymer coated magnetic nanoparticles. 
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Figure 3.1 Structure of Macromonomer 1 (a) and Macromonomer 2 (b). 
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3.2 Experimental Section 
 
 Materials. NaH (60%, dispersed in mineral oil), FeCl3.6H2O, FeCl2.4H2O, 
hexadecane (99%) and 4-vinylbenzyl chloride (90%) were purchased from the 
chemical supplier Acros Organics. Polyethylene glycol (Mn ~ 2000), tert-butyl 
bromoacetate (98%), iron (0) pentacarbonyl (99.999%), oleic acid (~99%), 
dioctyl ether (99%), trimethylamine N-oxide (98%), 2, 2'-azobis(2-
methylpropionitrile) (AIBN, 98%) and styrene (99%) were obtained from Sigma-
Aldrich. Tetrahydrofuran (THF) and other solvents were obatined from 
Mallinckrodt. THF was distilled over sodium before use. Deuterated solvents for 
NMR measurement were supplied by Cambridge Isotope Laboratories. 
 Measurements. NMR measurements were performed on a JEOL Eclipse 
+500 NMR spectrometer. Thermogravimetric analysis (TGA) was carried out on 
a Mettler-Toledo TGA/SDTA851e system. Scanning electron microscopy (SEM) 
images were obtained on a Hitachi S4700 field-emission SEM. Transmission 
electron microscopy (TEM) images were obtained using Hitachi 7000 and Hitachi 
HF-2000 TEM instruments. X-ray powder diffraction measurements were 
performed on a Scintag XDS-2000 system. A Quantum Design MPMS 
superconducting quantum interference device (SQUID) magnetometer was used 
to determine the magnetic properties of both iron oxide and polystyrene 
encapsulated magnetic nanoparticles at room temperature between 50 kOe.  
 Synthesis of macromonomer 1.  The structure of macromonomer 1 is shown 
in Figure 3.1. Synthesis details of macromonomer 1 are described in Chapter 2. 
  88
 Synthesis of macromonomer 2. Macromonomer 2 (Figure 3.1) was 
synthesized according to the following procedure, as shown in Scheme 3.2. NaH 
(~60%, 0.48 g, 12 mmol) was added to a 120 mL THF solution of polyethylene 
glycol (10 g, 5 mmol) at room temperature. The mixture was stirred for 
approximately 30 minutes and 4-vinylbenzyl chloride (0.84 g, 5 mmol) was added 
dropwise. The mixture was again stirred for 12 h at constant temperature of 35 oC. 
tert-Butyl bromoacetate (2 g, 10 mmol) was then added dropwise to the above 
mixture and stirred at 35 oC overnight. Upon the removal of insoluble salts via 
filtration, the filtrate was concentrated and precipitated into cold ether. The 
precipitants were then collected and dried in a vacuum oven at room temperature 
to obtain the macromonomer 2 (9.5 g, 85% yield). 1H NMR (500 MHz, CDCl3): δ 
7.40 (d, J = 8.2 Hz, 2 H), 7.34 (d, J = 7.8 Hz, 2 H), 6.27 (m, 1 H), 5.76 (dd, J = 
18.4, 0.9 Hz, 1 H), 5.24 (dd, J = 10.1, 0.9 Hz, 1 H), 4.58 (s, 2 H), 3.95 (s, 2H),  
3.90–3.40 (m, 180 H), 1.5 (s, 9) ppm. 13C NMR (125 MHz, CDCl3): δ 169.72, 
137.93, 136.97, 136.58, 128.00, 126.25, 113.81, 81.55, 72.97, 72.00-70.00 (m), 
69.43, 69.06, 28.17 ppm.  
 Synthesis of Fe3O4 (magnetite) nanoparticles. Oleic acid-stabilized Fe3O4 
magnetic nanoparticles were prepared by a conventional coprecipitation method 
with some modifications, as shown in Scheme 3.3. FeCl3.6H2O (11.6 g, 42.8 
mmol) and FeCl2.4H2O (4.3 g, 21.5 mmol) were dissolved in 400 mL of 
deionized water under nitrogen gas protection with vigorous stirring at 85 °C. 
NH3.H2O (25%; 15 mL) was added first to the solution, and then 9 mL of oleic 
acid was added dropwise into suspension within 20 min. After 10 minutes, the
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Scheme 3.2 Synthesis of Macromonomer 2. 
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FeCl3.6H2O (2 mol) + FeCl2.7H2O (1 mol) 
heating 
NH3.H2O 
oleic acid 
Fe3O4 nanoparticle 
Scheme 3.3 Synthesis route of Fe3O4 nanoparticles. 
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 magnetic precipitate was isolated from the solvent by magnetic decantation. The 
precipitate was then washed with deionized water 3 times to remove the excessive 
oleic acid, and the magnetic precipitate was re-dispersed in hexane to form 
magnetic fluid. 
 Synthesis of γ-Fe2O3 (maghemite) nanoparticles. Monodisperse γ-Fe2O3 
nanoparticles were prepared following a standard procedure pioneered by Hyeon 
et al. that has been previously detailed in the literature, as shown in Scheme 3.4.31 
To prepare monodispersed γ-Fe2O3 nanoparticles, 0.2 mL of Fe(CO)5 (1.52 mmol) 
was added to a mixture containing 10 mL of octyl ether and 1.28 g of oleic acid 
(4.56 mmol) at 100 oC. The resulting mixture was heated to reflux and kept at that 
temperature for 1 h, during which time, the initial orange color of the solution 
gradually changed to black. The resulting black solution was cooled to room 
temperature and 0.34 g of dehydrated (CH3)3NO (4.56 mmol) was added. The 
mixture was then heated to 130 oC under an argon atmosphere and maintained at 
this temperature for 2 h, whereupon it formed a brown solution. The reaction 
temperature was slowly increased to reflux and the reflux continued for 1 h, 
during which time the color of the solution gradually turned from brown to black. 
The solution was then cooled to room temperature, and ethanol was added to yield 
a black precipitate, which was then separated by centrifuging. The resulting black 
powder was able to be easily re-dispersed in such hydrocarbon solvents as 
hexane, octane, and toluene. 
 Synthesis of Fe3O4-encapsulated polymeric nanoparticles (I). Fe3O4 
nanoparticles were encapsulated in polystyrene particles by a miniemulsion 
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polymerization process, as shown in Scheme 3.5. 0.3 g Fe3O4 nanoparticles, 100 
mg AIBN and 0.12 g hexadecane, for use as an osmotic agent, were dissolved in 3 
g styrene to form the oil phase; 1.5 g of macromonomer 2 and 100 mg SDS were 
dissolved in 24 mL H2O to form the aqueous phase. After removing air by N2, 
these solutions were mechanically mixed and stirred for 1 h. To prevent 
polymerization, the miniemulsion was prepared by ultrasonicating the emulsion 
for 10 min at 0 oC. To initiate polymerization, the temperature was increased to 65 
oC and maintained for 4 h. A magnetic separator was used to harvest the particles 
containing the Fe3O4. 
 Synthesis of γ-Fe2O3–encapsulated polymeric nanoparticles (II).  γ-Fe2O3 
nanoparticles were also encapsulated in a polystyrene particles by a miniemulsion 
polymerization process, as shown in Scheme 3.5. Specifically, 0.3 g γ-Fe2O3 
nanoparticles, 100 mg 2, 2’-azobis(2-methylbutyronitrile) and 0.12 g hexadecane, 
again employed as an osmotic agent, were dissolved in 3 g styrene to form the oil 
phase; 1.5 g of macromonomer 2 and 100 mg SDS were dissolved in 24 mL H2O 
to form the aqueous phase. After removing air by using N2, these two solutions 
were mixed and stirred for 1 h. To prevent polymerization, the miniemulsion was 
prepared by ultrasonicating the emulsion for 10 min at 0 oC. To initiate 
polymerization, the temperature was increased to 65 oC and maintained at this 
temperature for 4 h. A magnetic separator was again used to harvest the particles 
containing the γ-Fe2O3 nanoparticles.  
 Synthesis of γ-Fe2O3–encapsulated polymeric nanoparticles with 
carboxylic acid (III). The same procedure was employed as that used to
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Fe(CO)5 + Oleic acid + Octyl ether 
heating 
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Scheme 3.4 Synthesis route of γ-Fe2O3 nanoparticles. 
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Scheme 3.5 Procedure for the encapsulation of magnetic nanoparticles 
in polymer particles by miniemulsion polymerization, including the 
following processes: 1. addition of water and surfactants; 2. mechanical 
stirring and sonication; 3. polymerization. 
1 2 3 
polymer monomer
H2O 
magnetic 
nanoparticles 
in monomer 
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 synthesize the γ-Fe2O3–encapsulated polymeric nanoparticles (II), except that 
macromonomer 1 was used rather than macromonomer 2. 
 Preparation of carboxylic acid-functionalized magnetic nanoparticles 
(IV). The carboxylic acid-functionalized magnetic polymer nanoparticles were 
obtained through the hydrolysis of γ-Fe2O3–encapsulated polymeric nanoparticles 
(II), as shown in Scheme 3.6. Specifically, sodium methoxide was added to a 
dispersion of magnetic polymeric nanoparticles (II) in water to adjust the pH 
value to 10. The resulting suspension was stirred at room temperature for 8 h. A 
magnetic separator was used to harvest the carboxylic acid-functionalized 
magnetic nanoparticles (IV) and washed with water three times. 
 Applications. The γ-Fe2O3–encapsulated polymeric nanoparticles (IV) were 
used in the rapid detection of Listeria monocytogenes by our collaborator Dr. 
Xiuping Jiang and Dr. Hua Yang in the Department of Food Science and Human 
Nutrition at Clemson University and as MRI contrast agents for in vitro 
application by our collaborator Dr. Jian-Ming Zhu at Wake Forest University, 
School of Medicine. More experimental details are available in Dr. Hua Yang’s 
dissertation32 and ref. 42. 
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Scheme 3.6 The preparation of carboxylic acid-functionalized 
magnetic nanoparticles (IV) from γ-Fe2O3-encapsulated polymeric 
nanoparticles (II). 
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3.3 Results 
 
 Synthesis of Fe3O4 nanoparticles.  Fe3O4 nanoparticles were obtained in a 
co-precipitation process by quickly adding a concentrated ammonium solution to 
a solution of Fe2+/Fe3+ with a molar ratio of 1:2 (Scheme 3.3). By adding oleic 
acid at temperatures above its melting temperature, the Fe3O4 nanoparticles were 
hydrophobized and were able to be easily dispersed in organic solvents such as 
hexane, octane and toluene. The morphological characteristics of those Fe3O4 
nanoparticles were observed by TEM, as shown in Figure 3.2. The size of the 
nanoparticles ranged from 10 and 15 nm.  
 Synthesis of γ-Fe2O3 nanoparticles. Highly crystalline and monodisperse 
magnetic γ-Fe2O3 nanoparticles were synthesized according to the procedure 
outlined in Scheme 3.4,31 illustrating that the nanoparticles possess a oleic acid 
ligand shell around the inorganic γ-Fe2O3 core. The nanoparticles obtained were 
characterized by TEM, X-ray powder diffraction, TGA and SQUID. 
 The synthesized oleic acid-coated maghemite nanoparticles were able to be 
spontaneously dispersed into hexane, forming a very stable dispersion. The 
formation of acid-coated maghemite nanoparticles and their average size and size 
distributions were investigated by both scanning electron microscopy (SEM) and 
transmission electron microscopy (TEM). The SEM specimen was prepared by 
depositing a small drop of maghemite nanoparticles in hexane onto a SEM sample 
holder, followed by the evaporation of the solvent. The TEM specimen was 
prepared by depositing a small drop of maghemite nanoparticles in hexane onto a 
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carbon-coated copper grid, followed by the evaporation of the solvent. Figure 3.3a 
and Figure 3.3b show respective SEM and TEM images of the oleic acid-coated 
maghemite nanoparticles. Both SEM and TEM results also indicate that all 
particles are well dispersed and have a narrow size distribution with an average 
diameter of 6.0 nm (Figure 3.3c). The X-ray powder diffraction pattern of the 
nanoparticles, shown in Figure 3.4, elucidate the nature highly crystalline 
structure. The position and relative intensity of all diffraction peaks match quite 
well with those of the standard γ-Fe2O3 reflections, as compared with (γ-Fe2O3, 
Powder Diffraction file, JC-POS 39-1346). Additional thermogravimetric analysis 
quantified the γ-Fe2O3 content in oleic acid-coated nanoparticles. Figure 3.5, 
detailing the TGA of the dried oleic acid-coated magnetite particles, shows a 33% 
loss in weight of organic materials at temperature up to 450 οC. The weight loss 
then ceased and remained constant at temperatures beyond this range, and up to 
500 οC. This temperature variance indicated that the particles contained 67 wt.% 
maghemite.   
 Magnetic susceptibility of γ-Fe2O3 powder samples were measured using a 
Quantum Design MPMS-5S SQUID magnetometer. Samples were placed inside a 
gelatin capsule, which was suspended in a plastic drinking straw attached to the 
sample transport drive. The magnetic susceptibility of the container was 
previously determined and its effects accounted for in data manipulation. 
Magnetic data were also corrected for core diamagnetism, and the hysteresis loops 
of the magnetic nanoparticle samples were recorded. As shown in Figure 3.6, the 
magnetization curves reached the saturation of 55.7 emu/g meghmite when the
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Figure 3.2 TEM images of Fe3O4 nanoparticles. 
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Figure 3.3 SEM (a) and TEM (b) of oleic acid-coated iron oxide 
and its size distribution (c). 
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Figure 3.4 Powder X-ray diffraction patterns of magnetic polymer 
nanoparticles (top) and oleic acid-coated iron oxide nanoparticles 
(middle). The γ-Fe2O3 pattern from the JCPDS database (bottom) is 
also shown for reference. 
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Figure 3.5 TGA of oleic acid-coated iron oxide (dashed) and 
MPNPs (solid). 
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Figure 3.6 Magnetic behavior of oleic acid-coated iron oxide (dashed) and 
MPNPs (solid). 
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applied magnetic fields increased to 5000 Oe, which is lower than the bulk 
meghemite value of 74 emu/g meghemite. The subsequent reduction in 
magnetization may be the result of surface effects.34,35 However, There was 
almost no noticeable hysteresis observed in the magnetization curves, suggesting 
that the oleic acid-coated maghemite nanoparticles are superparamagnetic, in the 
absence of both coercivity and remanence.36 
 Synthesis of Fe3O4-encapsulated polymer nanoparticles (I). A multi-step 
process was developed in order to obtain the magnetic polymer nanoparticles. A 
solution of Fe3O4 nanoparticles in styrene was initially added to an aqueous 
solution containing macromonomer and surfactant SDS. This mixture was then 
pre-emulsified and co-sonicated to form a stable miniemulsion of the 
monomer/magnetic nanoparticle dispersion in water. Lastly, this stable 
miniemulsion was polymerized at 65 °C to form polymer nanoparticles with 
magnetite cores, as shown in Scheme 3.5, which was verified by TEM, as shown 
in Figure 3.7. TEM also determined that the Fe3O4 nanoparticles occured as 
clumps within the polystyrene nanoparticles. 
 Synthesis of γ-Fe2O3-encapsulated polymer nanoparticles (III). To 
introduce carboxylic acids directly to the surface of magnetic polymer 
nanoparticles, carboxylic acids-containg macromonomer 1 was used for the 
miniemulsion polymerization. The resulting γ-Fe2O3-encapsulated polymer 
nanoparticles (III) were characterized by TEM as shown in Figure 3.8, elucidating 
the encapsulation of the resulting maghemite nanoparticles, which were pretty 
uniform in size. However, the surfaces of the resulting γ-Fe2O3-encapsulated
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100 nm 
Figure 3.7 TEM images of Fe3O4-encapsulated polymer 
nanoparticles. 
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200 nm 
Figure 3.8 TEM of MPNPs made from Macromonomer 1. 
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polymer nanoparticles (III) were also covered by maghemite nanoparticles, which 
may be attributed to the interaction of carboxylic acids and iron oxide.36 To 
circumvent subsequent carboxylic acid/iron oxide interaction, macromonomer 2, 
as shown in Figure 3.1, was used for the synthesis of γ-Fe2O3-encapsulated 
polymer nanoparticles (II). 
 Synthesis of γ-Fe2O3-encapsulated polymer nanoparticles (II). The 
identical procedure for the synthesis of γ-Fe2O3-encapsulated polymer 
nanoparticles (III) was applied to the synthesis of γ-Fe2O3-encapsulated polymer 
nanoparticles (II), except that macromonomer 2 was used rather than 
macromonomer 1.  
 Gel-phase NMR was used to analyze the resulting poly(ethylene glycol)-
coated magnetic polystyrene nanoparticles . For the measurement, MPNPs were 
first dispersed in diluted HCl to remove the iron oxide core, and those 
nanoparticles without iron oxide were then suspended in deuterated water. The 
gel-phase proton NMR spectrum of the polymeric nanoparticles is compared with 
that of macromonomer as shown in Figure 3.9. The PEG signal of nanoparticles at 
3.65 ppm was seen to be strong and broad, while exhibiting no signals from the 
polystyrene core.  
 Both SEM and TEM characterization were used to confirm the formation of 
nanoparticles and their average size and size distributions. The SEM specimen 
were prepared by depositing a small drop of the nanoparticle suspension onto a 
SEM sample holder, and the TEM sample was prepared by depositing a small 
drop of the same suspension onto a carbon-coated copper grid, followed by the 
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evaporation of the solvent. Figure 3.10 shows typical SEM and TEM images of 
magnetic polymer nanoparticles. SEM imaging indicates that the nanoparticles 
have a number average particle diameter of 130 nm (Figure 3.11). TEM shows 
those iron oxide nanoparticles occur as clumps within the magnetic polymer 
nanoparticles, with an average diameter of 55 nm (Figure 3.11). Figure 3.12 
shows typical SEM and TEM images of the same magnetic polymer nanoparticles 
from a different batch at a much lower concentration. As is clearly evident, these 
nanoparticles were dispersed quite well. 
 The phase analysis was performed by X-ray powder diffraction. It can be seen 
in Figure 3.4 that the spectrum of magnetic polymer nanoparticles is almost 
identical to that of the oleic acid-coated magnetic nanoparticles. TGA studies 
were also carried out for γ-Fe2O3-encapsulated polymer nanoparticles (II), also 
shown in Figure 3.5. The TGA curve of the magnetic polymer nanoparticles (II) 
shows a weight loss of approximately 88% caused by a temperature increase from 
300 oC to 500 oC, which means that the iron oxide content in the magnetic 
polymer nanoparticles is approximately 12%. 
 The magnetic properties of the synthesized magnetic polymer nanoparticles 
are of high interest for use in further applications. Figure 3.6 shows a typical 
hysteresis curve of magnetic polymer nanoparticles compared with that of oleic 
acid-coated iron oxide nanoparticles. Obviously, the resulting magnetic polymer 
nanoparticles are superparamagnetic with the saturation magnetization of value of 
25.6 emu /g maghmite, which is lower than that of ferrofluid iron oxide (55.7 
emu/g maghmite).  
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δ (ppm) 02468
Figure 3.9 1H NMR spectra of the macromonomer 2 (top) and 
polymeric nanoparticles in D2O (Gel phase NMR, bottom). 
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Figure 3.10 SEM (a) and TEM (b) of MPNPs (II). 
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Figure 3.11 (a) Size distribution of MPNPs (II); (b) Core size 
distribution of MPNPs (II). 
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500 nm 
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b 
Figure 3.12 SEM (a) and TEM (b) images of MPNMs (II) at lower 
concentration. 
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Application of γ-Fe2O3–encapsulated polymeric nanoparticles in rapid 
detection of Listeria monocytogenes. The results (Table 3.1, Figure 3.13) shown 
here were kindly provided by Dr. Xiuping Jiang and Dr. Hua Yang in the 
Department of Food Science and Human Nutrition at Clemson University.  
Application of γ-Fe2O3–encapsulated polymeric nanoparticles as MRI 
contrast agents. Results shown here were kindly provided by Dr. Jian-Ming Zhu 
at Wake Forest University, School of Medicine (Figure 3.14). 
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Figure 3.13A 
Figure 3.13B 
Figure 3.13C 
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Figure 3.13A RT-PCR detection of L. monocytogenes, 106( ) and 107 ( ) 
CFU/0.5 mL, in artificially contaminated milk without immunomagnetic 
nanoparticles. When DNA was directly extracted from the milk samples, there 
was no RT-PCR amplification even at the concentration of 107 CFU/ml of L. 
monocytogenes. (Courtesy of Dr. Xiuping Jiang and Dr. Hua Yang in the 
Department of Food Science and Human Nutrition at Clemson University.) 
 
Figure 3.13B RT-PCR detection of L. monocytogenes, 102 ( ), 103 ( ), 104 
( ), 105 ( ), 106 ( ), 107 ( ) CFU/0.5 mL in artificially contaminated milk 
after Dynabeads® -based IMS. For Dynabead®-based IMS in combination 
with RT-PCR, only two L. monocytogenes concentrations at 106 and 107 
CFU/ml were amplified. (Courtesy of Dr. Xiuping Jiang and Dr. Hua Yang in 
the Department of Food Science and Human Nutrition at Clemson University.) 
 
 
Figure 3.13C RT-PCR detection of L. monocytogenes, 102 ( ), 103 ( ), 104 
( ), 105 ( ), 106 ( ), 107 ( ) CFU/0.5 mL in artificially contaminated milk 
after IMPNPs-based IMS. when γ-Fe2O3–encapsulated polymeric 
nanoparticles-based IMS was combined with RT-PCR, samples with 
concentrations from 102 to 107 could be amplified and detected. (Courtesy of 
Dr. Xiuping Jiang and Dr. Hua Yang in the Department of Food Science and 
Human Nutrition at Clemson University.) 
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Figure 3.14A In vitro MRI images show slice from 1.0 mL agarose gel 
samples mixed with (a) Feridex IV (Ferumoxides injectable solution, Berlex 
Laboratories, Montville, NJ); (b) γ-Fe2O3-encapsulated polymeric 
nanoparticles; (c) PBS solutions.  Images were acquired with a 7T MRI 
scanner (Bruker Biospin, Germany).  Image parameters: slice thickness = 0.4 
mm, in-plane resolution = 120  um × 120  um, gradient echo sequence with 
TE = 3.2 ms.  For a and b, the net iron concentration was 0.0056 mg/ml.  
MRI signal voids shown as dark spots on images a and b are from iron oxide 
nanoparticles. 
 
Figure 3.14B MRI image shows examples of γ-Fe2O3-encapsulated magnetic 
polymer nanoparticles labeled stem cell imaging. 
A
a b c
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3.4 Discussion 
Synthesis of magnetic nanoparticles. In the literature, Fe3O4 
nanoparticles are traditionally created using procedures found in the literature, 
which involves grinding magnetite with long-chain hydrocarbon and a grinding 
agent, e.g. oleic acid.20 Subsequent Fe3O4 nanoparticle production procedures, 
commonly involved the use of NaOH, or NH3.H2O, as a base to coprecipitate 
ferrous (Fe2+) and ferric (Fe3+) ions, in the medium of an aqueous solution.21 
Although both processes result in the creation of tiny magnetite particles, the 
coprecipitation process is obviously more feasible for application in the 
production of more homogeneous magnetite particles. Therefore, this 
coprecipitation method was employed for use in the synthesis of the Fe3O4 
nanoparticles (Scheme 3.3). As can be seen in Figure 3.2, the size distribution of 
the Fe3O4 nanoparticles is considerably broad. Since Fe3O4 can be easily oxidized 
into Fe2O3, it is necessary to remove the air from the system during the 
preparation process. 
Organic solution-phase decomposition of the iron precursor at high 
temperatures has been widely used in the synthesis of iron oxide nanoparticles. 
For example, decomposition of Fe(CO)5 followed by oxidation can lead to high 
quality monodisperse γ-Fe2O3 nanoparticles (Scheme 3.4).31 In the work detailed 
in this dissertation, this decomposition method was employed for the synthesis of 
γ-Fe2O3 nanoparticles. As expected, highly crystalline and monodisperse γ-Fe2O3 
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nanoparticles were obtained, which can be extensively verified by SEM, TEM, 
TGA, X-ray powder diffraction, and SQUID. 
 Synthesis of iron oxide-encapsulated polymer nanoparticles. Iron oxide 
nanoparticles were encapsulated in polystyrene nanoparticles by a miniemulsion 
polymerization process, as shown in Scheme 3.5. Initially, a stable dispersion of 
magnetic nanoparticles in styrene is required. Oleic acid for that purpose was 
employed to make the particles hydrophobic, thusly preventing aggregation. Next, 
the stable dispersion was miniemulsified in water by using surfactant and 
ultrasound to form a stable miniemulsion. Since hexdecane was added to the 
monomer phase as a hydrophobe to prevent Ostwald ripening, the miniemulsion 
was already kinetically stable. Finally, the polymerization was begun by 
increasing the temperature. The brown color did not change during the 
polymerization, proving that the radical polymerization process did not 
significantly interfere with morphology of the magnetic nanoparticles. X-ray 
powder diffraction confirmed this observation, as shown in Figure 3.4. 
Macromonomer was utilized as both the stabilizer and comonomer during the 
polymerization process, which served as a surfactant to improve the miniemulsion 
stability. Macromonomer also participitated in the polymerization process and the 
formation of covalent bonds between styrene and macromonomer, thusly 
increasing the stability of the resulting magnetic polymer nanoparticles.  
 The principle of miniemulsion polymerization indicates that iron oxide 
nanoparticles should be encapsulated in polystyrene nanoparticles, which was 
indeed confirmed by TEM, as shown in Figure 3.11. However, the distribution of 
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maghemite nanoparticles within polymer nanoparticles was heterogenous, which 
was presumably due to the interaction between the maghemite moieties and a 
relative size- and content-specific destabilization of the miniemulsion droplets.25 
 Additionally, in the miniemulsion copolymerization of hydrophilic 
macromonomers and hydrophobic monomers, the formation mechanism indicated 
that hydrophilic chains were accumulated on the surfaces of particles, which was 
confirmed by proton NMR spectroscopy, as shown in Figure 3.10. In such 
conditions, no NMR signals were evident because that the polystyrene core was in 
the solid state.37,38,39 Only the hydrophilic tethers were able to be detected. 
Despite the absence of NMR signals, the NMR results were consistent with the 
nanoparticle structure of a polystyrene core and flexible surface. 
 As shown in Figure 3.6, the reduction of saturation magnetization after 
coating with polystyrene is probably the result of thick shell coatings on the 
magnetic nanoparticles.40 However, it is found that the γ-Fe2O3-encapsulated 
polymer nanoparticles (II) moved quite quickly under external magnetic field, 
thusly enabling their complete separation from water in a very short time. 
Therefore, the resulting magnetic force is strong enough for magnetic separation 
in various biological applications.  
 To increase the maghemite content, an indirect process based on 
miniemulsion polymerization has been recently introduced in the literature.21 In 
details, oleic acid coated maghemite particles are dispersed in octane, 
miniemulsified into water using sodium dodecyl sulfate (SDS) as a second 
emulsifier and subsequently carefully heated to evaporate the octane to obtain an 
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aqueous ferrofluid containing maghemite aggregates. For the encapsulation, a 
mixture of the maghemite aggregate dispersion and a styrene miniemulsion is co-
sonicated, followed by a polymerization process. Up to 40 wt% maghemite could 
be encapsulated by using this method. 
 Application of iron oxide-encapsulated polymer nanoparticles. The 
synthesized magnetic polymer nanoparticles were used to improve the capture 
efficiency of immunomagnetic separation of L. monocytogenes in comparison to 
commercially available anti-Listeria Dynabeads®. Then RT-PCR was applied to 
the cells captured by magnetic nanoparticles for a rapid and quantitative assay. As 
shown in Figure 3.13, the γ-Fe2O3–encapsulated polymeric nanoparticles-based 
IMS showed higher sensitivity and specificity of the subsequent PCR assays than 
that of anti-Listeria Dynabeads®, which might due to the following reasons: (1) 
Since γ-Fe2O3–encapsulated polymeric nanoparticles are much smaller than the 
commercially available Dynabeads®, they have higher surface-to-volume ration to 
contribute to the higher capture efficiency;41 (2) γ-Fe2O3 nanoparticles were 
encapsulated in polystyrene, providing high stability with various conditions; (3) 
Poly(ethyl glycol) is covalently attached on the surface of the magnetic polymer 
nanoparticles, which can not only increase the biocompatibility of the 
nanoparticles, but also provide enough active sites for the coupling of 
biomolecules. 
 γ-Fe2O3–encapsulated polymeric nanoparticles were also used as contrast 
agents for magnetic resonance imaging by our collaborator, Dr. Jian-Ming Zhu at 
Wake Forest University, School of Medicine, which showed similar results with 
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that of commercially available Ferumoxides injectable solution, the first liver-
specific MRI enhancement agent. 
 
3.5 Summary 
 
 In summary, a novel and effective protocol for the preparation of 
biocompatible poly(ethylene glycol)-coated magnetic polymer nanoparticles by 
the miniemulsion polymerization has been developed. Macromonomer served as 
both comonomer and stabilizer during the miniemulsion process. TEM 
observation reveals that these magnetic spheres are in the mean size of 130 nm 
with iron oxide nanoparticles encapsulated inside. During the miniemulsion 
polymerization, most of the magnetization compared to the oleic acid-coated 
magnetic nanoparticles is still preserved. When compared with Dynabeads® in the 
immunomagnetic separation, MPNPs-based PCR showed much higher sensitivity. 
Furthermore, MPNPs could be used as contrast agents for magnetic resonance 
imaging. 
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CHAPTER 4 
SOLUBLE NYLON-FUNCTIONALIZED CARBON NANOTUBES FROM 
ANIONIC RING-OPENING POLYMERIZATION FROM NANOTUBE 
SURFACE 
 
4.1. Introduction 
 The preparation of polymeric nanocomposites filled with single-walled 
carbon nanotubes (SWNTs) generally requires the nanotubes being 
homogeneously dispersed and compatible with the polymer matrix.1-3 An 
effective approach for these requirements is to functionalize the nanotubes with 
polymers that are identical or structurally similar to the matrix polymers.4 Among 
the widely pursued functionalization strategies is the “grafting-from” method, in 
which monomers or initiators are first attached to the nanotubes to serve as 
starting points for propagation.5-9 The grafting-from strategy is generally similar 
to in situ polymerization,10 but in a more controlled fashion. For example, the 
nanotube-bound radical initiators were used in the atom transfer radical 
polymerization to yield poly(methyl methacrylate)-, poly(n-butyl methacrylate)-, 
or poly(t-butyl acrylate)-functionalized carbon nanotubes.5 
 Nylon is an important commodity polymer with a wide variety of 
applications, and naturally, there has been much interest in nanocomposites of 
nylon with carbon nanotubes.11-18 For the investigation of these materials, the 
preparation of nylon-functionalized carbon nanotubes is highly relevant and 
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beneficial. In a typical synthesis of nylon 6, ε-caprolactam is used as monomer in 
the efficient anhydrous polymerization with a base (anionic) as initiator.19 In 
addition, the secondary amine in ε-caprolactam may be used to form an amide 
linkage with the defect-derived carboxylic acid moiety on the carbon nanotube 
surface. We report here that the covalent attachment of ε-caprolactam molecules 
to SWNTs could be the first step in a two-step grafting-from process of 
functionalizing the nanotubes with nylon 6. The second step was the anionic ring-
opening polymerization of the nanotube-bound ε-caprolactam species with the 
same monomers in bulk (Scheme 4.1). The same method was also employed for 
the functionalization of multi-walled carbon nanotubes (MWNTs) and vapor-
grown carbon nanofibers (VGCFs) with nylon 6. Polymer/carbon nanocomposites 
from these resulting nylon-functionalized carbon nanotubes and carbon nanofibers 
were characterized by NMR, TEM, SEM, TGA, and Raman spectra (Chapter 5).  
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Scheme 4.1. Synthesis of nylon 6-functionalized single-walled carbon 
nanotubes (Nylon-SWNT). 
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4.2. Experimental Section 
  
 Materials. ε-Caprolactam was purchased from Aldrich. Thionyl chloride 
and sodium were obtained from Alfa Aesar. Deuterated solvents for NMR 
measurements were supplied by Cambridge Isotope Laboratories. 
 The sample of SWNTs (arc-discharge method) was supplied by Carbon 
Solutions, Inc. It was purified by using a combination of thermal oxidation and 
oxidative acid treatment. In a typical experiment, a nanotube sample (1 g) was 
thermally oxidized in air in a furnace at 300 ºC for 30 min. After the thermal 
treatment, the remaining sample was added to an aqueous HNO3 solution (2.6 M), 
and the mixture was refluxed for 24 h. Upon centrifuging at 1,000 g to discard the 
supernatant, the remaining solids were washed with deionized water until neutral 
pH and then dried under vacuum. 
 Measurements. NMR measurements were performed on a JEOL Eclipse 
+500 NMR spectrometer and a Bruker Avance 500 spectrometer that is equipped 
with a high-resolution magic-angle-spinning (HR-MAS) probe designed 
specifically for gel-phase NMR. Optical absorption spectra were recorded on a 
Shimadzu UV3100 spectrophotometer. Raman spectra were obtained on a 
Renishaw Raman spectrometer equipped with a 50 mW diode laser source for 785 
nm excitation and a CCD detector. Thermogravimetric analysis (TGA) was 
carried out on a Mettler-Toledo TGA/SDTA851e system. Scanning electron 
microscopy (SEM) images were obtained on a Hitachi S4700 field-emission SEM 
system. Atomic force microscopy (AFM) analysis was conducted on a Molecular 
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Imaging PicoPlus system equipped with a multipurpose scanner. The height 
profile analyses were assisted by using the SPIP software distributed by Image 
Metrology. 
 Caprolactam-SWNT. A purified SWNT sample (50 mg) was mixed with 
thionyl chloride (10 mL), and the mixture was stirred and refluxed (70 EC) for 24 
h. Upon removal of excess thionyl chloride under vacuum, ε-caprolactam (5 g, 44 
mmol) was added. The mixture was stirred at 110 EC for 24 h, and then cooled to 
room temperature. Chloroform (20 mL) was added to the mixture, and the 
resulting suspension was filtered (0.22 :m PVDF membrane). The solid sample 
from the filtration was extracted with chloroform for 6 h in a Soxhlet extractor to 
remove any residual ε-caprolactam. Upon drying in vacuum at room temperature, 
the ε-caprolactam-functionalized SWNTs (caprolactam-SWNT) were obtained as 
a dark-colored powdery sample. 
Nylon-SWNT. A caprolactam-SWNT sample (50 mg) was mixed with ε-
caprolactam (10 g, 88 mmol), and sodium (40 mg, 1.7 mmol) was added to the 
mixture as initiator for the polymerization reaction at 140 EC under nitrogen 
protection for 24 h (Scheme 1). The reaction mixture was dissolved in formic acid 
(10 mL), precipitated into water (50 mL), and filtered (0.22 :m PVDF 
membrane). The resulting solid sample was washed successively (25 mL each) 
with formic acid, water, and formic acid again to remove sodium salts and those 
polymers not attached to the nanotubes (until no such polymers found in the 
filtrate). The cleaned sample was dispersed in formic acid (10 mL), followed by 
centrifuging (3,000 g) to retain the dark-colored supernatant. The solvent formic 
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acid was removed on a rotatory evaporator to yield nylon 6-functionalized 
SWNTs (Nylon-SWNT) as black solids. 
 
4.3. Results and Discussion 
 
 The functionalization of SWNTs with ε-caprolactam was the first step in 
the grafting-from process. The caprolactam-SWNT sample was generally 
insoluble in common organic solvents. Nevertheless, its dispersion in formic acid 
was used for 1H NMR measurement, yielding rather broad resonances (Figure 
4.1). The broadening was probably due in part to the heterogeneous nature of the 
dispersion, in addition to the high molecular weight and low mobility of carbon 
nanotubes. Better resolved proton signals were obtained from the same dispersion 
by using a high-resolution magic-angle-spinning (HR-MAS) probe designed 
specifically for gel-phase NMR (Figure 4.1). The resonances of the nanotube-
attached ε-caprolactam were systematically shifted upfield from those of the 
starting ε-caprolactam, especially for the methylene protons near the expected 
amide linkage (3.24 and 2.50 ppm vs 3.03 and 2.25 ppm, Figure 4.1). In the 
literature,20,21 similar upfield-shifts have been attributed to effects associated with 
the large aromatic ring current in nanotubes, which are more pronounced when 
the protons are closer to the nanotube surface. The NMR results are consistent 
with the covalent attachment of ε-caprolactam molecules to SWNTs. 
 The FT-IR spectrum of the caprolactam-SWNT sample exhibited 
absorptions at 2,930 cm-1 and 2,860 cm-1, corresponding to the stretching modes 
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of alkyl C-H in ε-caprolactam. As compared in Figure 4.2, the Raman spectrum 
(785 nm excitation) of the caprolactam-SWNT sample is similar to that of 
purified SWNTs, showing typical radial breathing mode (170 cm-1), D-band 
(1,310 cm-1), tangential G-band (1,580 cm-1), and D*-band (2,660 cm-1) features. 
The absence of luminescence interference reflects the expected low functional 
group content in the caprolactam-SWNT sample, also consistent with the poor 
solubility of the sample. In thermogravimetric analysis (TGA) of the sample 
under inert atmosphere, the covalently-attached ε-caprolactam on the nanotube 
surface could be selectively removed (or “thermal defunctionalization”),1,4,6-8 
which allowed an estimate of the ε-caprolactam content in the sample. The 
content was indeed low, ~7% (wt/wt), as expected. It corresponds to on average 
one ε-caprolactam for every 125 nanotube carbons. 
 The second step in the grafting-from process was the sodium-initiated 
anionic ring-opening polymerization to obtain nylon 6-functionalized SWNTs. 
The final Nylon-SWNT sample contained more than 70% of the starting SWNTs. 
The sample was soluble in some organic solvents, such as formic acid and m-
cresol, resulting in dark-colored but optically transparent solutions. 
 The 1H NMR spectrum of Nylon-SWNT in deuterated formic acid is 
compared with that of commercially available nylon 6 (Acros, Mn ~ 10,000) in 
Figure 4.3. The chemical shifts in the two spectra are generally similar, but the 
resonances of the nanotube-bound nylon moieties are obviously broader. Unlike 
in the dispersion of caprolactam-SWNT discussed above, the broadening here is 
probably due entirely to the nylon species being associated with the nanotubes
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 Figure 4.1 1H NMR spectra of ε-caprolactam-functionalized single-
walled carbon nanotubes (caprolactam-SWNT) dispersed in deuterated 
formic acid ((a): measured in solution probe, and (b): in high-resolution 
magic angle spinning probe) are compared with that of ε-caprolactam 
(c). 
δ (ppm)
1.01.52.02.53.0
c 
b 
a 
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Figure 4.2 Raman spectra (785 nm excitation) of the purified single-
walled carbon nanotube (SWNT) sample (top) and caprolactam-
SWNT (bottom). 
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Figure 4.3 A comparison of 1H NMR spectra of nylon 6-functionalized 
SWNTs (Nylon-SWNT, a) and nylon 6 (b) in deuterated formic acid solutions. 
δ (ppm)
1.01.52.02.53.0
b 
a 
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(high molecular weight and low mobility) because the Nylon-SWNT solution is 
homogeneous. 
 The nylon functionalities on the nanotube surface could also be selectively 
removed in TGA under inert atmosphere (thermally defunctionalized), similarly 
allowing an estimate of the nanotube content. According to the amount of residue 
at 500 EC, the Nylon-SWNT sample contained about 40% (wt/wt) of nanotubes.22 
 The optical absorption spectrum of Nylon-SWNT is shown in Figure 4.4. 
The broad S11 and S22 bands at 1,870 nm and 1,050 nm, respectively, are 
characteristic of the electronic transitions associated with the van Hove singularity 
pairs in semiconducting SWNTs.23 The spectral similarity to that of purified 
SWNTs suggests that neither the polymerization reaction nor the presence of 
nylon functionalities on the nanotube surface change in any substantial fashion 
the electronic transitions. Apparently, the nanotube electronic structures are 
largely preserved in the nylon-functionalized SWNTs, as also found in a number 
of other functionalizations that target the nanotube surface defect-derived 
carboxylic acids.4,7 
 The Raman characterization of Nylon-SWNT was hindered by 
overwhelming luminescence interference, quite different from the same 
characterization of the precursor caprolactam-SWNT (Figure 4.5). As reported 
recently,24 the substantial difference in the extent of luminescence interference in 
Raman measurements is an indication on how well the nanotubes are dispersed 
and functionalized. In the Nylon-SWNT sample, soluble in selected solvents to 
form transparent solutions, the nanotubes were well-dispersed and their surface
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Figure 4.4 Absorption spectra of nylon 6-functionalized single-walled 
carbon nanotubes (Nylon-SWNT, top) and the purified SWNT sample 
(bottom) on glass substrate. 
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Figure 4.5 Raman spectra (785 nm excitation) of the nylon 6-
functionalized SWNTs (Nylon-SWNT) before (top) and after (bottom) 
thermal defunctionalization (800 oC, N2). 
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defects were likely passivated as a result of the effective functionalization, thus 
corresponding to stronger nanotube defect-derived luminescence.1,24 The thermal 
defunctionalization obviously “un-dispersed” the nanotubes, suppressing or 
completely eliminating the luminescence interference. As compared in Figure 4.5, 
the Raman spectrum of the thermally defunctionalized Nylon-SWNT sample 
again exhibits features similar to those of purified SWNTs. 
 A direct SEM imaging of the nylon-functionalized SWNTs was somewhat 
difficult because of a significant amount of soft (nylon polymer) materials in the 
specimen (Figure 4.6). However, the removal of nylon via thermal 
defunctionalization obviously made the SEM analysis more straightforward, with 
the resulting image showing abundant SWNTs (Figure 4.6). AFM is applicable to 
the direct analysis of functionalized carbon nanotubes. For Nylon-SWNT, the 
specimen for AFM analysis was prepared by spraying a dilute formic acid 
solution of the sample onto a mica substrate. During the spraying, the substrate 
was kept at 120 EC to facilitate rapid solvent evaporation in an effort to preserve 
the original nanotube dispersion in the solution. A representative AFM 
topographic image from the analysis of such a specimen is shown in Figure 4.7. 
There are apparently abundant nanotubes of different lengths (hundreds of 
nanometers), mostly well-dispersed to the individual nanotube level according to 
the height analysis (Figure 4.7). It seems that the AFM specimen was unusually 
well-prepared (with a significant population of well-dispersed individual 
SWNTs), which probably benefitted from the use of the highly polar solvent 
formic acid. The solvent effect might be that the nanotube surface is charged, as 
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in the superacid dispersion25 or electrolyte-assisted dispersion of carbon 
nanotubes,26 thus resulting in more efficient exfoliation of the nanotube bundles 
(or preventing the functionalized SWNTs from aggregating). 
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Figure 4.6 Scanning electron microscopy (SEM) images of the 
nylon 6-functionalized single-walled carbon nanotubes (Nylon-
SWNT) sample before (top) and after (bottom) thermal 
defunctionalization (800 oC, N2). 
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Figure 4.7 Atomic force microscopy (AFM) topography image (top) 
and height analysis (bottom) of a nylon 6-functionalized single-walled 
carbon nanotubes (Nylon-SWNT) specimen (prepared by spraying the 
sample solution onto a heated mica substrate). 
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4.4. Summary 
 
In summary, the functionalization of SWNTs with nylon 6 was accomplished by 
using the grafting-from strategy in a two-step process, where the covalent 
attachment of ε-caprolactam molecules to nanotubes was followed by the anionic 
ring-opening polymerization of these bound ε-caprolactam species with the same 
monomers in bulk. The resulting sample was characterized systematically, and the 
results were supportive of the expected covalent functionalization of SWNTs by 
nylon 6. This is a relatively convenient but still reasonably controllable method to 
chemically modify carbon nanotubes with a commodity polymer of extremely 
wide uses. The solubility of the functionalized nanotube sample in some organic 
solvents may prove valuable to the homogeneous dispersion of SWNTs in nylon 
for high-quality nanocomposite materials. 
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CHAPTER 5 
FUNCTIONALIZATION OF CARBON NANOTUBES AND NANOFIBERS 
FOR IMPROVED DISPERSION IN POLYMERIC NANOCOMPOSITES 
 
5.1 Introduction 
 Recently, there has been intense research concerning the fabrication and 
application of polymer-carbon nanostructure composite materials.1-7 The carbon 
nanostructured materials especially carbon nanotubes (both single-walled 
(SWNT) and multi-walled (MWNT) carbon nanotubes) and vapor grown carbon 
nanofibers (VGCFs) have shown exceptional physical, mechanical, electrical, 
thermal, and optical properties.7-9 They are considered to be the ultimate 
reinforcing systems for polymer matrices. Significant advances have been 
reported in the processing of carbon nanostructured/polymer composite films6-7,10-
14 and fibers.4a,6,15-17 These studies agreed that the key factors to realize high 
quality nanoreinforcement of the composites are (1) a good dispersion of the filler 
in polymer matrix ; (2) a strong interfacial bonding between the filler and 
polymer; and (3) good alignment of the filler in polymer matrix. Previous 
methodologies explored for the dispersion of these carbon nanostructures were 
mainly by their sonication in polymer solution,16,18,19 in-situ polymerization,20-22 
and surfactant-assisted processing.23-25 Recently, chemical functionalization of 
these carbon nanostructures has emerged as an effective method for promoting 
their dispersion into polymeric matrices and in optimizing the performance of the 
nanocomposites.3,26-31 Several functionalization (covalent and non-covalent) 
approaches on the tube ends and side walls of MWNTs and VGCFs with organic 
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species like long chain alcohols and amines, dendrimers and polymers have been 
reported.3,26-31 The functionalization has been accomplished by either 
modification of surface-bound carboxylic acid groups on the nanotubes or by 
direct addition of reagents to the sidewalls of nanotubes. The most pursued 
strategy for the covalent grafting of polymers to nanotubes has been the process 
of “grafting from”, in which monomers or initiators are initially attached onto the 
nanotube surface, followed by the in-situ polymerization of the monomers.32-37 
For example, carbon nanotubes were functionalized with poly(methyl 
methacrylate), poly(n-butyl methacrylate), poly(tert-butyl acrylate), and 
polystyrene by using the nanotube-bound radical initiators in the atom transfer 
radical polymerization.32-37 We have recently used similar strategy to 
functionalize SWNTs with nylon-6 via a covalent attachment of ε-caprolactam 
molecules to nanotubes followed by the anionic ring-opening polymerization of 
these bound ε-caprolactam species with the same monomers in bulk.38  
 The chemical functionalization of CNTs has also been employed for the 
fabrication of high-quality polymeric carbon nanocomposites to improve both the 
degree of CNT dispersion in a polymer matrix and the interfacial bonding 
strength.39-40 The most appropriate method for this fabrication has been the use of 
polymers that are structurally and property-wise identical or close to the matrix 
polymer. This method ensures that the dispersed carbon nanotubes are compatible 
with the polymer matrix, thusly avoiding unwanted  “impurities” associated with 
the dispersion agents and any potential microscopic phase separation in the 
nanocomposites.39-40 The most commonly used techniques for the fabrication of 
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polymeric carbon nanocomposite materials relied on solution casting,20,41-43 melt 
spinning,44 and extrusion processing.15a,21,24 Recently, these composite materials 
were also processed into fiber yarns by using electrospinning technique and 
showed strong elongation, orientation, and distribution of nanotubes in the 
nanofibers.4a,15-17,45 This method is a nanofiber assembly technique that utilizes an 
external electrostatic field to generate small fibers with high surface areas and 
diameters on the nanometer scale. Achieving macroscopic orientation of MWNTs 
in the polymer matrix of nanofibers during electrospinning has been considered a 
necessary step towards the development of many meaningful technological 
applications.15,45 For instance, locally oriented nanotubes embedded in nanofibers 
electrospun from poly(ethylene oxide)- (PEO)/SDS/MWNT and PEO/Gum 
Arabic/MWNT were observed using transmission electron microscopy, in which 
SDS and Gum Arabic were used as binding agents in aqueous dispersions.45a 
Another approach used in the production of highly aligned MWNTs embedded 
within electrospun PAN nanofibers was achieved by collecting the nanofibers 
onto a winder with a surface velocities larger than the velocities of electrospun 
nanofibers. Exciting breakthroughs were achieved from this experimentation, 
demonstrating the potential of these carbon nanostructures in enhancing 
mechanical strength, electrical conductivity, and thermal conductivity.  
 As a new class of carbon nanofibers, vapor grown carbon fiber (VGCF) 
differs from carbon nanotubes in both its production method and lower cost. 
VGCFs have a high aspect ratio and nano-sized outer diameter of 50-200 nm, a 
hollow core of 30-90 nm.46,47 Because of its excellent thermal and electrical 
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conductivity, and good mechanical behavior, VGCF is of great interest and 
mostly used in the form of composites where the polymer required as an aspect of 
the matrices. For example, VGCF is usually used as reinforcement, adsorbent, and 
conductive filler. However, because of the very low surface free energy, nanosize, 
and low bulk density, the ability to disperse, stabilize and make VGCF compatible 
to polymer matrices still remains a challenge. 
 Although methodologies for the functionalization and dispersion of carbon 
nanotubes have been well developed and thoroughly reported in the literature, 
very little research has been reported on the dispersion and functionalization of 
VGCF. 31,48,49 Since VGCF has a similar surface structure to that of carbon 
nanotubes, the methodologies for the functionalization and dispersion of carbon 
nanotubes may be applied to the functionalization and dispersion of VGCFs. In 
this present dissertation, the functionalization of VGCFs with PPEI-EI through 
the amidation reaction has been reported, along with an extension of the grafting-
from strategy for the functionalization of both MWNTs and VGCFs with nylon-6. 
The functionalized samples were found to share solubility and compatibility with 
nylon-6 polymer in formic acid, which allowed for the formation of high-quality 
nylon-MWNTs and VGCFs composites nanoscale fiber mats through 
electrospinning. Results from characterizations of these solubilized carbon 
nanostructures and the nanocomposite fibers are presented and discussed. 
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5.2 Experimental Section 
 
Materials. ε-Caprolactam was purchased from Aldrich. PVA (MW ~ 70 
000-100 000, 99% hydrolyzed), thionyl chloride and sodium were obtained from 
Alfa Aesar. N,N'-Dicyclohexylcarbodiimide (DCC, 99%) and 4-
(dimethylamino)pyridine (DMAP, 99%) were obtained from Acros. 
Poly(propionylethylenimine) (PPEI, MW of 50,000 and 200,000), 1-
hydroxybenzotriazole (HOBT, containing less than 5% H2O) and trifluoroacetic 
acid (TFA, 99%) were from Sigma-Aldrich. Dimethyl sulfoxide (DMSO, 99.5%) 
and N,N’-dimethylformamide (DMF, 99%) were purchased from Burdick & 
Jackson and Acros, respectively, and dried over molecular sieves before use. 
Deuterated solvents for NMR measurements were supplied by Cambridge Isotope 
Laboratories. Dialysis membranes were supplied by Spectrum Laboratories. 
MWNT samples were supplied by Nanostructured and Amorphous Materials Inc. 
and purified via an oxidative acid treatment.3 In a typical purification, a MWNT 
sample (1 g) was suspended in a 50 mL of 60% HNO3 aqueous solution and 
sonicated in a bath (40 kHz) for 30 min. The mixture was then stirred for 24 h 
under reflux. After cooling to room temperature, it was diluted with 100 mL of 
deionized water and then vacuum-filtered through a 2.0 µm PTFE membrane. The 
solid was washed with deionized water until neutral pH and then dried under 
vacuum to give 0.7 g (70%) of carboxylic acid-functionalized MWNT. Figure 1 
shows a typical SEM image of purified MWNTs.  
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Figure 5.1 SEM image of purified VGCFs (a) and MWNTs (b). 
1 µm 
a 
1 µm 
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 Vapor grown carbon nanofibers (VGCF, PR-19-PS) were obtained from 
Applied Science Inc., Cedarville, OH. The diameter and length of the VGCFs 
were in the range of 60-200 nm and 30-100 µm, respectively. Surface oxidization 
of VGCFs was performed by heating VGCFs in concentrated nitric acid at 140 °C 
for 4 h. The product was filtered and washed with deionized water until neutral. 
The surface oxidized carbon nanofibers were vacuum-dried at room temperature 
for 2 days to remove residual water. Figure 5.1 shows a typical SEM image of 
purified VGCFs, with an average length of ~ 3 µm. 
PPEI-EI Copolymer. Poly(propionylethylenimine-coethylenimine) 
(PPEI-EI) random copolymers were prepared via partially hydrolyzing PPEI 
polymers.50 In a typical reaction, a PPEI sample (MW - 200,000, 1 g) was 
dissolved in methanol (5 mL). After water (50 mL) was added, methanol was 
evaporated via heating. Aqueous HCl (1 M, 2 mL) was added to the solution, 
followed by refluxing for 24 h. The reaction mixture was cooled to ambient and 
was then neutralized with aqueous NaOH to a pH of ~10. Upon the removal of 
water, the product was extracted with chloroform and precipitated into hexane, 
followed by drying under vacuum to yield the PPEI-EI copolymer as a white 
solid. 1H NMR (500 MHz, CDCl3): δ 3.6-3.2 (2*NCH2), 2.9-2.6 (2*NHCH2), 2.5-
2.2 (COCH2CH3), 2.1-1.8 (NHCH2), 1.2- 1.0 (COCH2CH3) ppm; 13C NMR (125 
MHz, CDCl3): δ 174 (C=O), 48.5 (2xNCH2), 44 (2xNHCH2), 26 (COCH2CH3), 
9.3 (COCH2CH3) ppm. The EI mole fraction in the random copolymer xNH was 
estimated in terms of the 1H NMR signal integrations 
    xNH = I2.8/(I2.8 + I3.4) 
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The mole fraction xNH could be controlled by varying the hydrolysis 
reaction time. For the PPEI-EI copolymers used in this study, the xNH value was 
generally ~20%. 
PPEI-EI-VGCF. VGCFs were functionalized with PPEI-EI through two 
different methods.50 The first is the acylation-amidation reaction method, using 
thionyl chloride as an acylation agent for subsequent amidation; The second is the 
direct heating method. In a typical direct heating reaction, a VGCF sample (25 
mg) was heated with PPEI-EI (MW ~ 200 000, 250 mg) at 160-180 oC under 
nitrogen protection for 12 h. After the reaction mixture was allowed to return to 
the ambient temperature, it was repeatedly extracted with chloroform. The 
functionalized carbon nanofibers in the dark chloroform solution were 
precipitated into hexane. The sample was re-dissolved in de-ionized water for 
dialysis (dialysis tubing cutoff molecular weight ~ 1 000 000) against freshwater 
for 3 days. Further purification included the precipitation from chloroform 
solution into hexane, followed by the solvent removal and drying under vacuum. 
The PPEI-EI-functionalized VGCFs were obtained as dark solids. 1H NMR (500 
MHz, CDCl3) δ 4.6-3.1, 2.9-2.7, 2.6-1.9, 1.5-0.5 ppm. 
In a typical acylation-amidation reaction, a purified VGCF sample (25 
mg) was refluxed with SOCl2 (4 mL) for 24 h to convert the carboxylicacids into 
acyl chlorides. Upon removing the excessive SOCl2 under vacuum, PPEI-EI (MW 
~ 200 000, 250 mg) was added to the acylated VGCFs and the mixture was kept 
at 160-180 °C under nitrogen for 24 h. The extraction and purification procedures 
were the same as those described above.  
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Caprolactam-MWNT. A purified MWNT sample (50 mg) was mixed 
with thionyl chloride (10 mL), and the mixture was stirred and refluxed (70 °C) 
for 24 h. Upon removal of excess thionyl chloride under vacuum, ε-caprolactam 
(5 g, 44 mmol) was added. The mixture was stirred at 110 °C for 24 h and then 
cooled to room temperature. Chloroform (20 mL) was added to the mixture, and 
the resulting suspension was filtered (0.22 µm PVDF membrane). Upon drying in 
a vacuum at room temperature, the caprolactam-functionalized MWNTs 
(caprolactam-MWNT) were obtained as a dark-colored powdery sample. 
Nylon-MWNT. A caprolactam-MWNT sample (50 mg) was mixed with 
ε-caprolactam (10 g, 88 mmol). Sodium (40 mg, 1.7 mmol) was then added to the 
mixture as an initiator for the polymerization reaction at 140 °C, under nitrogen 
protection, for 24 h (Scheme 5.1). The reaction mixture was dissolved in formic 
acid (10 mL), precipitated into water (50 mL) and filtered (0.22 µm PVDF 
membrane). The resulting solid sample was washed successively (25 mL each) 
with formic acid, water, and formic acid again to remove sodium salts and those 
polymers not attached to the nanotubes (until no such polymers remained in the 
filtrate). The solvent formic acid was removed on a rotatory evaporator to yield 
nylon-6-functionalized MWNTs (nylon-MWNT) as black solids. 
Nylon-VGCF. The reaction of caprolactam and then nylon 
functionalization with VGCFs (nylon-VGCF) was carried out by the same 
procedure with MWNTs. 
Measurements. NMR measurements were performed on a JEOL Eclipse 
+500 NMR spectrometer and a Bruker Avance 500 spectrometer equipped with a 
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high-resolution magic-angle-spinning (HR-MAS) probe designed specifically for 
gel-phase NMR. Optical absorption spectra were recorded on a Shimadzu 
UV3100 spectrophotometer. Raman spectra were obtained on a Renishaw Raman 
spectrometer equipped with a 50 mW diode laser source for 785 nm excitation 
and a CCD detector. Thermogravimetric analysis (TGA) was carried out on a 
Mettler-Toledo TGA/SDTA851e system. Scanning electron microscopy (SEM) 
images were obtained on a Hitachi S4700 field-emission SEM system. 
Transmission electron microscopy (TEM) analyses were conducted on Hitachi 
HF-2000 TEM and Hitachi HD-2000 TEM/STEM systems, both with the digital 
imaging capability. Atomic force microscopy (AFM) analysis was conducted on a 
Molecular Imaging PicoPlus system equipped with a multipurpose scanner. 
Electrospinning. The nylon-MWNT or nylon-VGCF was mixed with 
commercial nylon in formic acid in order to achieve viscoelastic and spinnable 
solution. The mixing ratio was controlled so that the nanotube/nanofiber content 
in the final fiber composite was 15 wt%. The nylon served also as the polymeric 
matrix of the electrospun nanofibers in which the nanotubes/VGCFs were 
embedded after solvent evaporation. The dispersions were directly used in the 
electrospinning process. The required volume (10 mL) of the solution was loaded 
into a syringe fitted to a syringe pump. The positive terminal of a Spellmann high 
voltage DC power supply was connected to the metallic needle of the syringe. A 
grounded stainless steel sheet placed 3 cm from the tip of the needle was used as 
the target to deposit the membranes, and the syringe pump was set to deliver the 
solution at a rate of 4 mL/h. When the first drop appeared at the tip of the needle, 
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the high voltage (15 kV) was applied. Electrospinning was carried out at room 
temperature in air for 1 h, and the samples were peeled from the target as free-
standing membranes. 
 
5.3 Results 
 
 PPEI-EI-VGCFs. The functionalization of MWNTs with amino 
polymers, such as PPEI-EI, by reaction with acrylic acid groups on the surface 
has been reported in the literature.50 Here, the same methods were applied to 
functionalize purified VGCFs with PPEI-EI through both the acylation-amidation 
(“SOCl2 method”) and the direct heating (“heating method”). PPEI-EI-VGCF 
samples are soluble in many common organic solvents such as chloroform and 
DMSO and also in water, forming dark-colored solutions. Since PPEI-EI is 
colorless, the dark color serves as a visual indication of VGCFs in the solution.  
 The solubility of PPEI-EI-VGCFs enabled high-resolution NMR 
characterization in solution. The 1H NMR spectra of the PPEI-EI-VGCFs in 
deuterated chloroform were compared with that of the parent PPEI-EI in Figure 
5.2. Upon the attachment of PPEI-EI to nanofibers, the spectra changed greatly in 
both character and composition. The signal broadening for PPEI-EI-VGCFs may 
be attributed to the attachment of the PPEI-EI to nanofibers as species of high 
molecular weight and low mobility.51 Another observed change was the absence 
of proton signals at ~2 ppm and 2.8 ppm from ethylenimine EI units. These 
signals could be either broadened beyond detection or shifted to regions where
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their overlap with other more intense signals made their identification impossible. 
This is consistent with the notion that the EI units are responsible for the 
functionalization reactions with the nanofiber surface-bound carboxylic acids.52
 The nanofiber content in the PPEI-EI-VGCFs was obtained through a 
TGA experiment conducted with a heating rate of 10 oC in nitrogen. The 
decomposition temperature of PPEI-EI was determined to be much lower than 
that of the carbon nanofibers (Figure 5.3). Therefore, the PPEI-EI polymers in 
PPEI-EI-VGCFs may be selectively removed in a relatively slow TGA scan, 
leaving behind the thermally defunctionalized VGCFs at temperature of 700 oC. 
According to the TGA traces, the carbon nanofiber contents in the PPEI-EI-
VGCFs prepared from acylation-amidation and direct heating are approximately 
66% and 39%, respectively. 
 The two functionalization reactions were evaluated in terms of the amount 
of VGCFs being functionalized and solubilized, with this determination being 
based upon the mass balance for the nanofibers. The two functionalization 
methods resulted in different amounts of soluble VGCFs (Table 5.1). For 
example, appoximately 44% of VGCFs was soluble in solution for acylation-
amidation method, which is higher than that for the direct heating methods 
(15.6%). The results for the functionalization of MWNTs with PPEI-EI via 
acylation-amidation method was were also shown in Table 5.1, with 46% 
functionalization yield based on the mass balance for MWNTs. 
 Nylon-MWNT and Nylon-VGCF. The functionalization of SWNT with 
nylon was successfully developed through anionic ring-opening polymerization of 
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Figure 5.3 TGA traces (heating rate 10 °C/min in continuous 
nitrogen flow) of PPEI-EI-VGCFs from acylation-amidation (a), 
PPEI-EI-VGCFs from direct heating (b), and PPEI-EI polymer 
(c). 
Temperature (oC)
200 400 600 800
R
el
at
iv
e 
W
ei
gh
t (
%
)
0
20
40
60
80
100
120
a 
c
b 
  
 
 
161
  
 
 
162
carprolactam from nanotube surface.38 Here we applied the same grafting from 
strategy to the functionalization of MWNTs and VGCFs with nylon-6, which 
includes the covalent attachment of ε-caprolactam molecules-to-nanotubes, and 
the anionic ring-opening polymerization of these bound ε-caprolactam species 
with the same monomers in bulk (Scheme 5.1 and Scheme 5.2). Both nylon-
MWNT and nylon-VGCF samples were found to be soluble in several polar 
solvents, such as formic acid and m-cresol, resulting in stable and dark-colored 
homogeneous solutions. Figure 5.4 shows four vials containing equal volumes of 
formic acid and nearly equal masses of purified VGCFs (Vial A), nylon-VGCFs 
(Vial B), nylon-MWNTs (Vial C), and purified MWNTs (Vial D). These results 
clearly indicate that both purified VGCF and MWNT were completely insoluble 
in formic acid, while both nylon-MWNT and nylon-VGCF formed stable, dark-
colored solution that exhibited no discernible particulate materials while also 
remaining stable for a period of at least 4 weeks. Since nylon is colorless, the dark 
solution color serves as a visual indicator for the presence of MWNTs and 
VGCFs in solutions.  
 More direct evidence for the presence and the dispersion of MWNTs and 
VGCFs in dark-colored solutions was demonstrated by STEM and AFM analyses. 
For nylon-MWNT, the specimen for AFM analysis was prepared by spraying a 
dilute formic acid solution of the sample onto a mica substrate. During the 
spraying, the substrate was kept at 120 °C to facilitate rapid solvent evaporation 
in an effort to preserve the original nanotube dispersion in the solution. Figure 5.5 
shows a representative AFM topographic image from the analysis of such a
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specimen, with well-dispersed individual MWNTs. The STEM samples were 
prepared by placing a few drops of nylon-VGCFs solution onto carbon-coated 
copper grid, followed by evaporation of the solvent. As shown in Figure 5.6(a), 
individual VGCFs rather than aggregates or bundles are obtained after 
functionalization. At a high resolution (Figure 5.6(b)), the images show that 
VGCFs surfaces are partially covered by amorphous materials, which are most 
likely the attached nylon polymers.53 
 To evaluate the content of both the MWNTs and VGCFs, the nylon 
functionalities on the surfaces of these nanostructures were thermally removed in 
TGA. Figure 5.7 shows TGA traces of the nylon-functionalized MWNTs and 
VGCFs in reference to commercially available nylon 6 (Acros, Mn ~ 10 000). 
The experiments were carried out in nitrogen atmosphere with a heating rate of 10 
°C/min. Because there is no meaningful weight loss for the purified pristine 
MWNT and VGCF samples below ~600 °C, the weight loss, as a result of thermal 
defunctionalization, can be used to estimate the MWNT and VGCF contents in 
these functionalized samples. According to the residual sample weights at 600 °C, 
the estimated MWNT and VGCF contents in the soluble fractions are 77%, 56%, 
respectively. These are obviously rough estimates because of possible 
contributions from the trapping of functional groups in the nanotube aggregates 
after defunctionalization. 
 The solubility of nylon-functionalized MWNTs and VGCFs enabled high-
resolution NMR characterization in solution. The 13C spectra of nylon-
functionalized MWNTs and VGCFs are compared with that of neat nylon-6 
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(Acros, Mn ~ 10 000) in Figure 5.8. All spectra were acquired at the same 
solution concentration of 3 mg/mL in regular formic acid by using deuterated 
chloroform for locking at room temperature. The 13C spectra of nylon-attached to 
MWNTs and VGCFs are mostly similar to that of free nylon, with the spectra of 
the attached nylon being somewhat broader. 
 The nylon-MWNTs and nylon-VGCFs samples were characterized by 
resonance Raman spectroscopy. Figure 5.9 shows the Raman spectrum of nylon-
MWNTs compared with those of purified MWNTs and thermally 
defunctionalized nylon-MWNT samples. The Raman spectrum (785 nm 
excitation) of nylon-MWNTs are subject to strong luminescence interference, 
similar to those found in other functionalized carbon nanotubes.38 After the 
thermal treatment of these samples at 600 oC in a nitrogen atmosphere to remove 
the functional groups, the strong luminescence interference was completely 
eliminated. From the comparison in Figure 5.9, the spectrum of the thermally 
defunctionalized nylon-MWNT sample again exhibits the characteristic MWNT 
peaks at 1310 cm-1 (D-band), 1580 cm-1 (tangential G-band), and 2660 cm-1 (D*-
band), which shows that no fundamental difference between the solubilized and 
pristine MWNTs. 
 Resonance Raman spectroscopy was also used to characterize nylon-
VGCFs (Figure 5.10). Similar luminescence interference to that of functionalized 
nylon-MWNT sample was observed with the D-band at 1310 cm-1, tangential G-
band at 1580 cm-1 feature, which indicates that the VGCFs are well-dispersed in 
the nylon-functionalized VGCF sample. As expected, a removal of the functional 
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Figure 5.9 Raman spectra (785 nm excitation) of the nylon-MWNTs 
sample before (top) and after (middle) TGA and purified MWNTs 
(bottom). 
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Figure 5.10 Raman spectra (785 nm excitation) of the nylon-VGCNFs 
sample before (top) and after (middle) TGA and caprolactam-SWNT 
(bottom). 
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groups in the thermal defunctionalization of the funtionalized VGCF sample 
eliminated the luminescence interference, with the Raman spectrum showing the 
same characteristic features of purified VGCFs. However, compared with 
MWNTs, there is no D*-band at 2660 cm-1 in the Raman spectrum of VGCFs. 
 The shared solubility and full compatibility of nylon-functionalized 
MWNTs and VGCFs with nylon-6 polymer in formic acid allowed their intimate 
mixing in solution and thereby enabled the fabrication of high quality 
nanocomposite fibers. The electrospinning parameters used to produce the 
composite fibers were chosen from a set of optimized parameters after a series of 
systematic studies were carried out to determine the effects of flow rate, polymer 
and carbon nanostructures concentration, the voltage applied and the tip-to-target 
distances on the spinnability, jet stability, and morphology of the polymer fibers, 
with and without MWNTs and VGCFs encapsulation. 10-12 wt % of the polymer 
solution was found to be the appropriate concentration for a more stable polymer 
jet. Because the as-prepared nylon-functionalized MWNTs and VGCFs solutions 
exhibited low shear and elongational viscosity, the nanofibers could not be 
formed by electrospinning. These solutions were then mixed with additional 
commercial nylon in formic acid in order to increase the viscosity and thus 
provide adequate spinnability for electrospinning. The mixture was electrospun 
and directly deposited on the flat collector or around the rotating wheel to collect 
a rope of oriented nanofibers with controlled diameter. Figure 5.11 shows an 
example of scanning electron microscopy (SEM) images of nylon nanofibers 
containing MWNTs. The fibers resembled typical electrospun nylon-6 fibers with 
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an approximate diameter of 50-200 nm. The first attempt to image MWNTs 
within the nanofibers proved to be very difficult due to the low contrast between 
the polymeric matrix and the nanotubes and to the small diameter of the 
nanotubes relative to the nanofibers. Since the diameter of the VGCFs is much 
larger than nanotubes, in some cases it was possible in some cases to identify 
VGCFs within some of the nanofibers. Consequently, TEM analysis was better 
able to selectively distinguish and image both MWNTs and VGCFs within 
nanofibers (Figure 5.12). Since the MWNTs and VGCFs possess a high electron 
density compared with the nylon polymer matrix, they appear as darker tubular 
structures embedded in the nylon polymer. As shown in Figure 5.12, it is clearly 
evident that individual MWNTs and VGCFs were successfully embedded in the 
dispersing polymer matrix. In many regions of the electrospun nanofibers the 
embedded nanotubes appeared to be well-oriented along the fiber axis. 
 Another major goal of this work was to achieve macroscopic orientation 
of MWNTs and VGCFs in the polymer matrix of nanofibers during 
electrospinning. The high aspect ration of MWNTs and VGCFs makes them 
highly anisotropic in nature and their orientation is considered to be of significant 
importance towards the creation of many meaningful technological applications. 
By aligning them in the polymer matrix, the strength, stiffness, electrical and 
thermal properties of the composite can be controlled. We have developed an 
effective method for electrospinning various polymers into well-aligned fibers by 
combining electrospinning with a cylinder collector with high rotating speed and 
additional mechanical stretching of the film. However, this very high speed
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(~1700 round per minute) electrospinning process only managed to improve the 
alignment of the film to a certain extent. Therefore, to complete the alignment 
process, thin film was made from the electrospun nanofibers and mechanically 
stretched at 100 ̊C by applying a constant load. The same approach was applied in 
the orientation of MWNTs and VGCFs in the polymer matrix of nanofibers. SEM 
images in Figure 5.13 show that these polymeric carbon nanocomposites fibers 
(200-400 nm) are well aligned in the direction of the stretch. 
 
5.4 Discussion 
  
 There are many examples in the literature reporting the successful surface 
functionalization of carbon nanotubes. For example, Haddon et al. have shown 
that single-walled carbon nanotube bundles can be exfoliated with 2.6 M nitric 
acid to create individual SWNTs bearing terminal carboxylic acid groups.54 Since 
vapor grown carbon nanofibers have similar surface structure to that of carbon 
nanotubes and possess edge-site carbon atoms of each graphene layer terminating 
the nanofiber surface, they are especially suitable for surface functionalization. 
Consequently, we used the same approach for the functionalization of MWNTs 
with PPEI-EI to functionalize VGCFs with PPEI-EI.50 Mechanistically, the 
functionalization of VGCFs with PPEI-EI probably occurs through the nanofiber 
surface-bound carboxylic acid moieties, which are produced during the 
production and the subsequent oxidative purification under strong acidic 
conditions. Compared to the direct heating method, the acylation-amidation 
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method was more efficient for the functionalization of VGCFs with PPEI-EI, 
which might be a result of the higher reactivity of nanofiber-bound acyl chlorides 
than nanofiber-bound acrylic acids. As illustrated in Figure 5.2, Figure 5.3, and 
Table 5.1, VGCFs showed similar results with MWNTs. When acylation-
amidation method was used, the functionalization yields for both VGCFs and 
MWNTs were around 40%. 
 Both MWNTs and VGCFs were functionalized and solubilized with nylon 
6 via the anionic ring opening polymerization method developed in Chapter 4.38 
Compared to the functionalization of MWNTs and VGCFs with PPEI-EI, the 
anionic ring opening polymerization is more efficient. The functionalization of 
MWNTs/VGCFs with PPEI-EI involved the bonding of PPEI-EI to the nanotube- 
and nanofiber-bound carboxylic acid groups and the attachment of a small 
number of chains hindered diffusion of additional PPEI-EI macromolecules to the 
surface, thereby leading to low grafting density; while the anionic ring opening 
polymerization method involved the immobilization of small molecules of 
caprolactam onto the nanotube/nanofiber surface followed by in situ surface 
initiated polymerization to generate the nylon 6-functionalized 
nanotubes/nanofibers. Therefore, the functionalized carbon nanotubes/nanofibers 
with high grafting density are easily synthesized through the anionic ring opening 
poltmerization method. 
 The functionalization of VGCFs with nylon 6 described here is probably 
initiated in a manner shown in Figure 5.14. The first step is the attachment of 
caprolactam to the surface of carbon nanofibers through the amidation reaction 
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(Figure 5.14(b)). The second step in the anionic polymerization is believed to be a 
reaction of a caprolactam ring with the catalyst sodium to form a caprolactam 
anion and hydrogen (Figure 5.14(a)). The third step involves the nucleophilic 
attack of caprolactam anion on the endocyclic carbonyl group of caprolactan-
VGCFs, resulting in an ionic intermediate that may be stabilized by the 
potentially overlapping orbitals in the resonance systems of the adjoining amide 
groups (Figure 5.14(c)). The system can be protonated by reaction with 
caprolactam monomer to continue the polymerization process (Figure 5.14 (d and 
e)). Generally speaking, the release of ring strain is the driving force of the 
polymerization. 
 According to this VGCF functionalization process, nylon 6 was covalently 
attached to the surface of carbon nanotubes and carbon nanofibers, which was 
confirmed by the 13C spectra of nylon-MWNTs and nylon-VGCFs as shown in 
Figure 5.8. The signal broadening for nylon-MWNTs and nylon-VGCFs may be 
attributed to the attachment of nylon to carbon nanotubes and nanofibers as 
species of high molecular weight and low mobility.51  
 The good dispersion of carbon nanotubes and nanofibers in the 
functionalized samples was reflected by the strong luminescence interference in 
resonance Raman measurements (Figure 5.9 and 5.10). This strong luminescence 
background, as discussed in the literature,3 is an indication of the well dispersion 
and functionalization of nanotubes with nylon. The luminescence may be 
attributed to well-passivated nanotube and nanofiber surface defects which act as 
traps for the photoexcitation energy. Upon stabilization by the functional groups, 
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these surface defects may become strongly luminescent. After the functional 
groups were removed by TGA, the strong luminescence was completely 
eliminated. The elimination may due to the known inter-tube quenching effect 
associated with the bundling of nanotubes and nanofibers.  
 As shown in Figure 5.9 and Figure 5.10, it was interesting to notice that 
the D-band of VGCFs was broader than that of MWNTs while the width of G-
bands were closely adjacent to one another. When compared with MWNTs, no 
D*-band at 2660 cm-1 was detected in the Raman spectrum of VGCFs. According 
to Lee et al.,55 the broadening of D-band and absence of D*-band may be 
interpreted as an indication of interior structural quality of VGCF compared to 
carbon nanotubes. 
 Electrospinning was used for the fabrication of polymer/carbon 
nanocomposite nanofibers with an internal macroscopic orientation of carbon 
nanotubes and nanofibers. TEM images (Figure 5.12) clearly show that the 
individually embedded nanotubes and nanofibers appeared to be well-oriented 
along the fiber axis. This exact orientation towards the axis is a result of the 
original dispersion which mainly contained individual nanotubes rather than 
aggregates or bundles. Before electrospinning, the MWNTs and VGCFs in the 
solution were randomly oriented. However, due to the elongation of the fluid jet, 
the nanotubes/nanofibers are now oriented along the streamlines of the 
electrospinning solution during the electrospinning.45 
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Figure 5.14 Mechanisms for the functionalization of carbon nanotubes 
and carbon nanofibers with nylon 6. 
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5.5 Summary 
 
 The methodologies developed for the functionalization and solubilization 
of carbon nanotubes can be applied for the functionalization and solubilization of 
vapor-grown carbon nanofibers. The resulting functionalized VGCFs are 
dispersed well in solution and can be used for the fabrication of high-quality 
polymer/carbon nanocomposites. 
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